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Abstract 
Optically active alcohols are useful building blocks for the synthesis of 
biologically active' and structurally interesting compounds.2 These types of compounds 
have been prepared by asymmetric hydrogenation of olefins (eq. I), and enantioselective 
hydrogenation of ketones and alpha or beta-keto esters using gaseous hydrogen with 
homogeneous and heterogeneous catalyst systems.3 
Eq. 1 
(S)-BinapRu(oA~)~ 
Geraniol (R)-Citronellol 
100% yield, 96.99% ee 
In addition to straightforward asymmetric hydrogenation, which results in high 
enantioselectivity, there has been recent interest in the preparation of these compounds 
using asymmetric transfer hydrogenation (ATH) where the hydrogen source comes from a 
solvent. 
This method has been extensively used for aldehydes and ketones4 because of the 
favorable properties of the hydrogen donor as well as the operational simplicity. Recent 
work in our group has shown that this reaction is amenable to a new class of substrates, 
allylic alcohols (eq. 2). Geraniol was converted to citronellol in 90 - 95 % yield and 95 - 
I 
2 
Hashiguchi, S.; Fujii, A,; Takehara, 1.; Ikariya, T.; Noyori, R. J. Am Chem. Soc. 1995, 117,7562-7563. 
Masumma, K.; Hashiguchi, S.; Ikariya, T.; Noyory, R. J.  Am. Chem, Soc. 1997, 119,8738-8739. 
Noyory, R. Asymmetric Catalysis in Organic synthesis, Wiley: New York, 1994. 
4 
a) Iyer, S.; Varghese, J.P. Chem. Soc., Chem, Commun. 1995,465; b) Ahn, K. H.; Ham, C.; Kim, S. K.; 
Cho, C. J.  Org. C k m .  1997,62,7047; c) Yamada, I.; Noyori, R. Organic LRtters 2000,2 (22), 3425; d) 
Wills, M.; Palmer, M.; Smith, A.; Kenny, J.; Walsgrove, T. Molecules2000,5,4. 
98 % ee (R) using isopropyl alcohol as the solventmydrogen source and an in situ 
prepared catalyst Ru-(S)-tolBWAP. 
Eq. 2 
uoH Ru-(S)-tolBWAP_ 
0.01 M P A  soh. 
Geraniol 2 eq KOHRu (R)-Citronellol 
SIC 1011 90-95% yield 
95-98% ee 
An investigation on the mechanism of this ATH reaction was conducted. The 
results from the deuterated experiments lead us to propose that the olefin isomerizes to 
the en01 followed by a transfer hydrogenation reaction (eq. 3). The isomerization takes 
place by a metal-assisted 19-hydrogen shift via a z-ally1 i d  
hydrogenation step is in good agreement with the mechanisitic 
studied transfer hydrogenation of carbonyl groups. 
Eq. 3 
nediate. The transfer 
ps found in the well- 
DOR - 
0 R H 
R f OR D 9 
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CHAPTER 1: A REVIEW OF ASYMMETRIC HYDROGENATION AND 
ASYMMETRIC TRANSFER HYDROGENATION 
1.1 Introduction 
Asymmetric hydrogenation is an important tool in synthetic organic chemistry. It 
has dramatically changed the procedures of chemical synthesis since its modest 
beginnings in the 1960s. It all began by the discovery of Wilkinson that 
triphenylphosphinelRh complexes could catalyze hydrogenation of olefins in so~ution.~ 
The field really got underway when Knowles and Homer reported the first examples of 
asymmetric hydrogenation of prochiual olefins with chiral phosphine/Rh complexes in 
1968.~ Asymmetric catalysis became so important in organic synthesis that three 
researchers in this area were awarded with the 2001 Nobel Prize in chemi~try,~ which 
was shared among William S. Knowles and Ryoji Noyori for their work on catalytic 
asymmetric hydrogenation reactions and Barry K. Sharpless for his work on catalytic 
asymmetric epoxidation reactions. Today, about half of the commercial drugs in use are 
chira17 and in 2005, the worldwide sales of single-enantiomer drugs reached 225 billion 
US dollars based on estimates from Technology Catalysts International (TCI).' In this 
chapter, the origin, the use and the mechanism of various types of homogeneous 
asymmetric reductions will be reviewed. 
1.2 Overview of Asymmetric Hydrogenation 
1.2.1 Wilkinson's Catalysts 
5 Knowles, W. S.; Noyori, R. Acc. Chem. Res. 2007,40, 1238. 
6 http: / /nobelpr ize .org/nobeIIprizes lche~s l  
' Noyori, R. Angew. Chem. In!. Ed. 2002,41,2008. 
The first efficient catalysts in the homogeneous hydrogenation of unsaturated 
compounds were reported by Geoffrey Wilkinson in 1966 with the discovery of its 
tris(triphenylphosphine)halogenorhodium( complexes.9 Previous catalysts, particularly 
the cobalt(Q-cyanide system, had limited use as they were efficient only in the 
reduction of conjugated double bonds (butadiene, a$-unsaturated acids and aldehydes), 
but not in isolated ethylenic linkages.9 
Scheme 1.1: Preparation of Wilkinson's TriphenylphosphineiRh Catalyst Complexes. 
RhX3(H20)3 + CH3CH20H + 3 PPh3 -+ RhX(PPh3)3 + CH3CHO + 2 HC1+ 3 H20 
(X = C1, Br, I) 
The Wilkinson's catalysts were prepared by the reaction of excess 
triphenylphosphine with rhodium(III) halide in ethanol (Scheme 1.1). In homogeneous 
solution, the tris(tripheny1phosphine) complexes were reported to be exceedingly active 
catalysts for rapid homogeneous hydrogenation of unsaturated compounds containing 
isolated olefinic and acetylenic linkages! 
The mechanism (Figure 1.1) involves the initial dissociation of one or two 
triphenylphosphine ligands to give 14 or 12-electron complexes, respectively. Oxidative 
addition of hydrogen to the metal center generates the 16 electron Rh complex. 
Subsequent insertion of the olefin follow by reductive elimination results in the formation 
of the reduced product.'0 
http://www.pharmatech.com/ 
9 Osborn, J. A,; Jardine, F. H.; Young, J. F.; Wilkinson, G. J.  ChemSoc. (A)  1966,171 1 .  
10 James, B .  R. Homogeneous Hydrogenation, John Wiley & Sons: New York, 1973. 
Figure 1.1: The Mechanism of Hydrogenation with Wilkinson's 
Tris(tripheny1phosphine)-chlororhodium(I) Catalyst. 
1.2.2 Asyrnrnetrk Hydrogenation with Chiral Phosphine Ligands 
The rust examples of catalytic asymmetric hydrogenation were reported by 
Knowles and Homer in 1968 with the synthesis of their chiral phosphinelrhodium 
complexes." Knowles reported the hydrogenation of a-phenylacrylic acid with 0.15 mole 
% of RhC13L3 (L = (-)-methylpropyl-phenylphosphine), which gave 2-phenylpropanoic 
acid in 15% ee at 60 "C, and the hydrogenation of itaconic acid to succinic acid in 3% ee 
at 25 and 60 OC (Scheme 1.2)." a That same year, Homer reported that a-ethylstyrene and 
a-methoxystyrene could be hydrogenated to (S)-(+)-2-phenylbutane in 7 - 8 % ee and 
(R)-(+)-1-methoxy-1-phenylethane in 3 - 4 % ee, respectively, in the presence of 0.5 
mole % of the same chiral ligand at normal pressure and room temperature." 
Scheme 1.2: Asymmetric Hydrogenation with Chiral Phosphine Ligands. 
COOH 
RhC 3L3 
"2 *& / 
MeOH 6C 'C 
15% ee 
COOH RhC 3L3 COOH HOOCA "2 * HOOCA 
MeOH 256C 'C 
Scheme 1.3: Asymmetric Hydrogenation with Chiral PhosphineIRh Catalysts. 
R4 
0.05% [Rh(l,5-cyclo-octadiene)(CI)L] 
H2, 10-55 psi HOOC 'NHC0R5 
Alcoholic solvent, 25-50 OC 
-80% ee 
R4 = H, Ph, M ~ O ~ - ( O H ) - C ~ H ~ ,  Me0 4 (Ac0)-CsH3 
R5 = Ph, Me 
R' = eanisyl, manisyl, Me, Cyclohexyl 
R~ = Me, Ph, cyclohexyl 
R3 = Ph, PI", ~ r ' ,  Me 
1 a*; ; :e  1 
CAMP 
I 1  
a) Knowles, W. S.; Sabacky, M. 1.3. Chem. Soc., Chem. Commun. 1968, 1445. b) Homer, L.; Siegel, H. 
Angew. Chem. Int. Ed. 1968, 7, 942. 
A few years later, Knowles and coworkers synthesized a new series of chiral 
phosphine ligands, which gave moderate to good enantiomeric e ~ c e s s . ' ~  This resulted in 
the discovery of o-anisylmethylcyclohexylphosphine (CAMP), giving 80% enantiomeric 
excess (Scheme 1.3). 
Several a-acylaminoacrylic acids were hydrogenated to their corresponding a- 
amino acids using 0.05 mole % of the rhodium catalysts under 10 - 55 psi of hydrogen at 
25 - 50 "C. Of particular interest were the high optical purities obtained with o- 
anisylmethylcyclohexylphosphine (CAMP) when applied to various acylphenylalanine 
substrates. These yields ranging from 85 - 90 % show that almost complete 
stereospecificity was achieved considering that the phosphine ligand was only 95% ee. 
On the other hand, the lower optical yields, 4 0 %  ee, indicate that the ligand is not the 
only factor influencing the outcome of the product. 
The o-anisylmethylcyclohexylphosphine (CAMP) catalyst gained its major 
importance when it was applied to the preparation of commercial drug L-DOPA, an anti- 
Parkinson drug (Scheme 1.4).13 
Several catalysts (Figure 1.2) were screened in the hydrogenation step, the key 
step in L-DOPA synthesis, and the best enantiomeric excess (88%) was then obtained 
with CAMP, which resulted in an isolated yield of about 70%. This was the first time 
enzymatic-like selectivity was obtained with a man-made catalyst.13 Later, the ligand was 
replaced with 1,2-bis(pheny1orthoanisylphosphino)ethane (DIPAMP), which gave 95% ee 
and an isolated yield of 75 - 80 %. 
12 Knowles, W. S.; Sabacky, M. J.; Vineyard, B. D. Chem. Commun. 1972,lO. 
l 3  Knowles, W .  S .  Angew. Chem. Int. Ed. 2002,41,1998. 
17 
Scheme 1.4: The Use of CAMP in L-DOPA Synthesis. 
HO* + 3 FOOH Ac~O 
H3C0 NHAc H3C0 I 
NHAc H2 
* 
[Rh(CAMP)] NHAc 
H3C0 
/ 
HO 
L-DOPA 
Figure 1.2: Phosphine Ligands Screened in the Asymmetric Hydrogenation Step in 
L-DOPA Synthesis. 
Entry Ligand % ee 
1.2.3 Asymmetric Hydrogenation with Cz-Chiral Biphosphine Ligands 
The field of asymmetric hydrogenation really got underway with the discovery of 
the first active Cz-chiral biphosphine ligand 4,5-Bis-[(diphenylphosphanyl)-methyl]-2,2- 
dimethyl-[1,3]dioxolane (DIOP).I4 Previous example of C2-chiral phosphine ligand 
(Entry 1, Figure 1.2) resulted in no enantiosele~tivit~.'~ It was believed that to get 
enantioselectivity, the chirality needed to be directly on the phosphorous atom, but 
Kagan's discovery of the DIOP ligand has proven otherwise. 
The active catalyst was prepared in situ by adding two equivalents of DIOP to a 
benzene-ethanol solution of [Rh-(cyclooctene)2C1]2. The resulting solution catalyzed the 
hydrogenation of a$-unsaturated carboxylic acids in 95% yields and 63 - 72 % ee 
(Scheme 1.5). 
Scheme 1.5: Asymmetric Hydrogenation with DIOP. 
R' R2 R' 
>=( [Rh(l)(L)Clsolrent], 3.3 mol % HF2 
H COOH H2 H COOH Et3N, Benzene-EtOH 
95% Yield. 63-72% ee 
(1) R' = H, R2= Ph 
(2) R1=Ph, R2= NHAc 
(3) R1 = H, R2 = NHCOCH2Ph 
14 Dang, T. P.; Kagan, H. B. Chem. Commun. 1971,481. 
19 
These results have generated a lot of interest and for the next decade many 
efficient C2-chiral biphosphine ligands were discovered. However, these ligands were 
useful only on enamides, en01 esters and carboxylic acids (Figure 1.3).13 Other 
compounds like a-arylacrylic acids and unfunctionalized olefins worked poorly or were 
simply inactive. 
Figure 1.3: The Use of Diphosphine Ligands in Asymmetric Hydrogenation. 
Chiraphos 
(Bosnich) 
BPPM 
(Achiwa) 
(Rhone-Poulene) 
PNNP 
(Giogo) 
BPPFA 
(Kumada) 
enamides 
,4 ( k h  0 
o=( 
CH3 
enol eters 
COOH 
carboxylic acids 
Scheme 1.6: Asymmetric Hydrogenation of Functionalized Olefins with Ru-BINAP. 
P(c6H5)2 
P(C6H5)2 
S-BINAP 
4 p 0 ( 0 c H 3 ) 2  NHCHO NHCHO 
It wasn't until 1980 - 1986 that the scope of asymmetric hydrogenation was 
expanded with the discovery of ruthenium 2,T-bis(dipheny1phosphino)-1,l'-binaphthyl 
(RulSINAP) complexes. This axially di-symmetric Cz biphosphine ligand coupled with 
ruthenium allows asymmetric hydrogenation of a wide range of functionalized olefins 
including a-arylacrylic acids, a$- and P,y-unsaturated carboxylic acids, ally1 and homo- 
allylic alcohols, 2-acyl-benzylidene-1,2,3,4-tetrahydroisoquinolines, a- and P- 
aminoacids, as well as a-amino phosphonic acids (Scheme l.6).I5 
The Ru-BINAP complexes were also useful in the asymmetric hydrogenation of a 
wide range of functionalized ketones, wherein coordination of nitrogen, oxygen, and 
halogen groups near the carbonyl group directed the reactivity and stereoselectivity of the 
product (Scheme 1.7). The reactions are normally conducted in alcoholic solvents under 4 
- 100 atm hydrogen pressure at room temperature to give the corresponding alcohols in 90 
- 100 % ee.I5 
Scheme 1.7: Asymmetric Hydrogenation of Functionalized Ketones with Ru-BINAP. 
I S-BINAP 
15 Ni, R.; Ohkuma, T .  Angew. Chem. Int. Ed. 2001,40,40. 
22 
The 2,Z-bis(dipheny1phosphino)-1,l'-binaphthyl (BINAP) worked well with Rh 
(I) and Ru ( Q  but gave opposite enantiomers. This is due to the operation of different 
catalytic cycles, a dihydride mechanism for Rh (I) versus a monohydride pathway for Ru 
( Q . ~  The dihydride mechanism for Rh (I) (similar to Figure 1.1) proceeds via oxidative 
addition of Hz, to diastereomeric Rh-substrate chelate complexes, followed by stepwise 
transfer of the hydrides to the coordinated olefin; which involves a +1/+3 redox process. 
In contrast to the monohydride pathway for Ru(II), the ruthenium center remains in the +2 
oxidation state throughout the catalytic cycle. Figure 1.4 illustrates the mechanism of 
RU(II)BINAP.'~ 
The reaction has been shown to proceed via a ruthenium intermediate 2 formed by 
heterolysis of Hz by the Ru complex 1. Interaction of 2 with the P-keto ester forms 
complex 3. Protonation of the keto oxygen follow by hydride transfer generates the Ru- 
hydroxy ester 4, which interacts with a solvent molecule to release the chiral P-hydroxy 
ester. The cationic ruthenium 5 reacts with another hydrogen molecule to regenerate 2, 
which reenters the catalytic cycle. 
The Ru-BINAP complexes have some important applications in the synthesis of 
many commercial  compound^.^ For example, the anti-inflammatory drug Naproxen can 
be obtained in 97 % ee from the corresponding a-aryl-acrylic acid using this catalyst.'6 
Similarly, citronellol can be obtained in 96 - 98 % ee from geraniol or nerol without over 
reduction to the dihydrocitronellol'7 (Scheme 1.8). 
16 a) Ohta, T.; Takaya, H.; Kitamura, M.; Nagai. K.; Noyori, R. J. Org. Chem. 1987,52,3174; b) Vineyard 
B.; Knowles, W.; Sabacky, M.; Bachman, G.; Weinkauff, D. J. Am. Chem. Soc. 1977,99,5946. 
17 Takaya, H.; Ohta, T.; Sayo, N.; Kumobayashi, H.; Akutagawa, S.; Inoue, S.; Kasahara, I.; 
Noyori, R. J. Am. Chem. Soc. 1987,109,1596. 
Figure 1.4: The Mechanism of Ru(II)BINAP Catalyzed Hydrogenation of P-Keto Esters. 
Hz 
RuC12(BINAP)(solvent)2 - RUHCI(BINAP)(SO~V~~~)~ 
1 - HCI 2 
solvent 
3 
R 
[RuHCl(BlNAP)(~olvent)~] 
2 
4 
solvent 
Hz 
5 
Scheme 1.8: Application of Ru-BINAP in Commercial Syntheses. 
geraniol 
> 30 atm. Hz 
MeOH 
- A 
(R)citronellol 
99% yield 
96-98% ee 
- 
135 atm. Hz 
MeOH 
The Ru-BINAP system was considered a major breakthrough for extending the 
scope of asymmetric hydrogenation to a variety of functionalized olefins and ketones. 
None of the previous chiral ligands (mono- and bi-phosphine) offered this kind of 
diversity. The Ru-BINAP system is thought to come close as a universal asymmetric 
hydrogenation catalyst. However, this catalyst system was not efficient in the 
hydrogenation of non-functionalized ketones, particularly with a~eto~henone.~ 
1.2.4 Asymmetric Hydrogenation with BZNAP/Diamine Ligands 
In 1995, the hydrogenation of simple ketones became possible with the discovery 
of BINAPIdiamine-ruthenium complexes. These catalysts, particularly RuClz(xy1- 
BINAP)-DAIPEN, were very efficient in the presence of a strong base (KOH, KOtBu) in 
the enantioselective hydrogenation of a range of aromatic, heteroaromatic, and olefinic 
ketones in i s ~ ~ r o ~ a n o l . ' ~  For example, acetophenone and its derivatives can be 
hydrogenated to the corresponding alcohols in 94 - 96 % ee. In addition, a$-unsaturated 
ketones can now be hydrogenated in the presence of a weaker base (K2CO3) to give the 
corresponding chiral allylic alcohols (Scheme 1.9).Is 
The mechanism of the BINAPIdiamine-ruthenium reduction is shown to be 
different from the mine-free BINAP reduction. The high reactivity and chemoselectivity 
of the BINAPIdiamine system is due to a bifunctional mechanism (Figure 1.5).7 
Scheme 1.9: Asymmetric Hydrogenation of Simple Ketones with Ru-BINAP/Diamine. 
RU-(S)-XylBlNAP-DAIPEN 
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IPA, 
- d C H 3  
X X 
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94-96% ee (S) 
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H3C CH2CH(CH3)2 
H 10 atm. H2 - H & V C H 2 C H ( C H 3 ) ,  (3) 
IPA, K2C03 H 
100% yield, 90% ee 
I8 a) Ohkuma, T.; Koizumi, M.; Doucet, H.; Pham, T.; Kozawa, M.; Mwata, K.; Katayama, E.; Yokowaza, 
T.; lkaryaT.; Noyori, R. J. Am. Chem. Soc. 1998,120, 13529. b) Ohkuma, T.; Ooka, H.; Ikariya, T.; 
Noyori, R. J. Am. Chem. Soc. 1995,117,10417. 
Figure 1.5: a) Non-classical Metal-Ligand Bifunctional Mechanism and Conventional 
[2+2] Mechanism. b) Catalytic Cycle of Hydrogenation of Ketones with 
Ru(QBEVAP/Diarnine. 
bare 1 base I I H' 
Figure 1.5 (a) shows the six-membered ring intermediate describing a Ru hydride 
species possessing an NH2 ligand, whose protons (Ru-H and N-H) are stimultaneously 
transferred to the C=O linkage, without direct coordination of the carhonyl substrate to 
the metaL7 Figure 1.5 (b) shows a more detailed mechanism. The 18-electron ruthenium 
hydride 2 reacts with the carbonyl group via the six-membered ring intermediate shown 
in Figure 1.5 (a) to give the product alcohol and the 16-electron complex 3. The high 
turnover efficiency of this catalyst system is believed to originate from the alternating 
charge arrangement of HS- RU" N'- H" on the six-membered ring intermediate. 
Therefore, the hydride at the ruthenium center has sufficient nucleophilicity and the NH 
hydrogen-bonding ability activate the carbonyl substrate. The ruthenium complex 3 reacts 
with Hz in the presence of base and a protic solvent to regenerate 2, which goes back to 
the catalytic cycle via complex 4 and complex s . ~ '  Is 
Figure 1.6: Application of BINAP/Diamine-Ruthenium Complexes in Commercial 
Compounds. 
fluoxetine hydrochloride 
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The BINAPIdiamine-ruthenium complexes have many industrial applications. For 
example, (R)-neobenodine, a PI-receptor agonist, can be synthesized by doing asymmetric 
hydrogenation of o-bromo-p7-methylbenzophenone as a key step.I9 Other applications 
include (R)-denopamine, another pi-receptor agonist, the antidepressant (R)-fluoxetine, 
the antipsychotic BMS 181 100, and (S)-duloxetine, a potent inhibitor of serotonin and 
norepinephrine (Figure 1.6).' 
1.2.5 Summary of Asymmetric Hydrogenation 
Asymmetric hydrogenation is an important tool in organic synthesis. Since the 
discovery of the first chiral phospinem complexes in the late 1960s, this field in organic 
synthesis has enabled efficient synthetic routes, including the asymmetric synthesis of 
many medicinally and industrially important compounds. Over the years, asymmetric 
reduction has expanded to various types of substrates, which include functionalized 
olefins, functionalized ketones and simple ketones. These transformations became 
possible with the discovery of more reactive and chemoselective ligandcatalyst systems. 
I The chiral mono-phosphine ligands/modium catalyst systems @gure 1.2), 
particularly CAMP, gave moderate enantioselectivity (-80%) in the asymmetric reduction 
of unsaturated amino acids and carboxylic acids. Later, the enantioselectivity was 
increased to up to 99% ee with the discovery of the diphosphine ligands (Figure 1.3). The 
asymmetric reduction of a broader range of olefins (Scheme 1.6) and functionalized 
ketones (Scheme 1.7) became possible with the discovery of the BINAPIruthenium 
catalyst system. Today, even the long time challenging a-phenylacrylic acid and its 
-- 
19 Ohkuma, T.; Koizumi, M.; Ikehira, H.; Yokozawa, T.; Noyori, R. Org. Lett. 2002,2,659. 
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derivatives as well as various simple ketones (Scheme 1.9) can be hydrogenated in high 
yield and good enantiomeric excess (90 - 96 %) with the BJNAPldiamine ruthenium 
complexes. 
Despite the high reactivity and chemoselectivity obtained with these catalyst 
systems, safer procedures are desired among organic chemists. Most asymmetric 
hydrogenations are conducted under high pressure, thus, special equipment is required. 
An alternate procedure is Asymmetric Transfer Hydrogenation (ATH), which eliminates 
the need for high pressure vessels. An overview on ATH follows below. 
1.3 Overview of Asymmetric Transfer Hydrogenation 
Asymmetric transfer hydrogenation is also a well studied area in organic 
chemistry.20 It is a convenient method to reduce carbonyls, imines and activated olefins 
without the use of hydrogen pressure or hazardous reducing In recent years, 
asymmetric transfer hydrogenation has been classified second to gaseous hydrogenation 
among the methodologies suitable for this This method is being extensively 
studied because of the low cost and favorable properties of the hydrogen donor as well as 
operational simplicity. Transfer hydrogenation can take place under two major types of 
mechanisms: metal-template concerted process [Meenvein-Pomdorf-Verley (MPV) 
reduction] and metal hydride mediated process (hydridic reduction).20a An overview of 
these two processes is given in the following section. 
20 a) Gladiali, S.; Alberico, E. Chem Soc. Rev. 2006,35,226; b) Hashiguchi, S.; Fujii, A,; Takeham, L.; 
Akayira, T.; Noyon, R J. Am. Chem. Soc. 1995,117,7562; c) Mizushima, E.; Yamaguchi, M.: Yamagishi, 
T. Chem. Lett. 1997,237; d) Palmer, M.; Walsgrove, T.; Wills, M. J. Org. Chem. 1997,62,5226. 
1.3.1 Meenvein-Ponndorf-Verley (MPV) Reduction 
The first example of transfer hydrogenation is dated back to 1925 when Meenvein 
and Schmidt performed the hydrogenation of an aldehyde with aluminum ethoxide in 
ethanol?' The same year, Verley reported the reduction of butyraldehyde using the same 
aluminum ethoxide in the presence of geraniol as a hydrogen donor.22 A year later, 1926, 
Ponndorf extended the scope to the reduction to ketones with aluminum isopropoxide in 
isopropanol (Scheme 1.10)?' A major drawback of these types of reductions is that a 
stoichiometric amount of the metal catalyst is required. 
Scheme 1.10: Transfer Hydrogenation with Metal Alkoxide Catalysts. 
1 eq A (OEt)3 A 
* R H 
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The mechanism of this reaction, known as MPV mechanism, proceeds through a 
concerted six-membered ring transition state (Figure 1.7).24 The alcohol reactant 
coordinates to the metal to form 7. The carbonyl is activated upon coordination to 7 to 
form 8, which undergoes rearrangement to form 10 via the six membered-ring 
21 Meenvein, H.; Schmidt, R. Liebigs Ann. Chem. 1925,444,221. 
22 Verley, A. Bull. Soc. Chim Fr. 1925.37.537. 
2, Ponndorf, W. Angew. Chem. 1926,39,138. 
24 Graauw, C. F. de; Peter, 1. A.; Bekkum, H. V.; Huskens, J. Synthesis 1994,1M17. 
intermediate 9. Both the carbonyl compound and the reducing alcohol are bound to the 
metal via the six-membered ring intermediate and the reduction occurs without the 
formation of any metal hydride. 
Figure 1.7: Meenvein-Ponndorf-Verley (MPV) Mechanism. 
An enadoselective example of the Meenvein-Ponndorf-Verley (MPV) type of 
reduction was reported in 1993 by David ~vans.2' Following Kagand's lead in his C2 
chiral backbone catalyst,I4 chiral samarium(IQ was able to reduce carbonyl groups in 
high enantioselectivity via transfer hydrogenation using the MPV mechanism. Several 
aryl ketones were converted to their corresponding alcohols in high enantiomeric excess 
when 5 mole % of the samarium catalyst was used in the presence of isopropyl alcohol as 
hydrogen donor at ambient temperatures (Scheme 1.1 
Scheme 1.11: Transfer Hydrogenation with Chiral Samarium Catalyst. 
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Unlike the previous stoichiometric examples with aluminum alkoxides, this MPV 
reduction is catalytic in samarium. However, the samarium catalyst seems to have a 
special affinity for isopropyl alcohol as the hydrogen source; other alcohols such as 3- 
pentanol, cyclopentanol, or benzhydrol were ineffective. 
1.3.2 Transfer Hydrogenation via MetaLHydride Mediated Mechanism 
The second category of transfer hydrogenation involves the formation of a metal 
hydride by interaction of the hydrogen donor with the catalyst, which subsequently 
transfers the hydride to the ~ubstrate.'~ This mechanism is typical for transition metals 
[Ru (E), Rh (I), Ir(I)] and depending on the metal, a mono or dihydride metal species may 
be involved. The most popular hydrogen donors include formic acidltriethylamine and 
isopropyl alcohol (PA). During the process of transfer hydrogenation with P A ,  the P A  
oxidizes to acetone, which also competes for hydrogen and as a result makes transfer 
hydrogenation a reversible process.20a The equilibrium of the reaction can be shifted 
toward the desired product by using P A  as the reaction solvent. 
Scheme 1.12: Transfer Hydrogenation with Iridium-Hydride Catalyst. & 5 mo % HIrC 2(Me2SO)i 
/ A IPA ref ux 
12-24 h 
Early examples of transition metal catalyzed transfer hydrogenation were reported 
27 by Henbest in the 1960s. For example, the carbon-carbon double bond in 
benzylideneacetophenone and related compounds was reduced with 5 mole % of the 
26 Backvall, J.  E. J. Organomer. Chem. 2002,652,105. 
27 Samec, J. S. M.; Backvall, J.  E.; Anderson, P. G.; Brandt, B. Chem. Soc. Rev. 2006,35, 237. 
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acidic iridium catalyst in boiling isopropyl alcohol (PA) (Scheme 1.12).~' The metal 
hydride HIrCl~(Me2S03)~ was believed to be generated from an acidic solution of iridium 
tetrachloride/dimethylsulfoxide in boiling IPA. 
In 1991, metal-hydride transfer hydrogenation was optimized with the addition of 
a strong base. Aliphatic and aromatic ketones were reduced with 0.1 mole % of 
RuC12(PPh3)3 and 2.4 mole % of sodium hydroxide in isopropyl alcohol at 82 "C (Scheme 
1.13):~ The reactions remained in equilibrium giving up to 89% conversion. However, 
distillation of the by-product acetone resulted in full conversion of the  substrate^.^^ This 
was an upgrade compared to the previous non basic reactions, which required high 
temperature (150 - 200 "c)?~ The base was believed to generate a more nucleophilic 
alkoxide ion, which resulted in faster attack to the metal, thus enhancing the reaction 
rates3' 
Transition metalcatalyzed transfer hydrogenation may result in the formation of 
chiral products if conducted in the presence of chiral ligands. The ligands feature various 
combinations of phosphorous, nitrogen, oxygen, or sulfur.20a Many prochiral ketones, 
imines and activated olefins, which are limited to conjugated acid and amino acid 
derivatives, may be hydrogenated via asymmetric transfer hydrogenation. The 
enantiomeric excess (ee) of the product depends on the substrate type, the catalyst and the 
reaction conditions. 
For example, the carbonyl group in acetophenone can be reduced with 1 mole % 
of (lR,2S)-(+)cis-l-amino-2-indanol, L1, 0.25 mole % of the ruthenium complex 
28 J. Trocha-Grimshaw, J.; Henbest, H. B. Chem. Commun. 1967,544 
29 
30 
Chowdhury, R. L.; Backvall, I. E. Chem. Commun. 1991, 1063. 
Morton, D.; Cole-Hamilton, D. I. Chem Commun., 1988, 1154. 
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[R~Cl&-cymene)]~ A and 2.5 mole % of KOH in isopropanol at room temperature to 
give 70% yield and 91% ee (Table 1.1, entry 1 and Scheme 1.14).~' At lower temperature 
(0 "C), the same reaction gave 49% yield with a slight increase in the enantiomeric excess 
to 93% (Table 1.1, Entry 2). When the ligand was substituted with the less rigid (R)- 
phenylglycinol, L2, the enantiomeric excess dropped to 23% but the yield increased to 
95% at room temperature (Table 1.1, entry 3). The use of another ruthenium arene 
complex [RuCl2(mesitylene)]2 B gave 73% yield and 82% ee (Table 1.1, entry 4). When 
the catalyst was replaced with ruthenium arene complex B and (S,S)-TsDPEN, L3, the 
yield and the enantiomeric excess increased to 95% yield and 97% ee (Table 1.1, entry 
5).31 This last result is comparable to what obtained from gaseous hydrogenation (Scheme 
1.9, eq. 1). The rate and enantioselectivity of asymmetric transfer hydrogenation may also 
be affected by the bulkiness and electronic properties of the subst~ate.~' 
Scheme 1.13: Transfer Hydrogenation with RuCI2(PPh3)3. 
0.1 mol % RuCI2(PPH3), 
2.4 mol % NaOH 
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31 Palmer, M.; Walsogrove, T.; Wills, M. J. Org. Chem. 1997,62,5226. 
32 Hashiguchi, S.; Fujji, A.; Takehara, 1.; Ikariya, T.; Noyori, R. J. Am. Chem. Soc. 1995, 117,7562. 
Scheme 1.14: Transfer Hydrogenation with RuCl(arene)/Chiral Ligand Complexes. 
IPA. KOH 
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Figure 1.8: Conventional Mechanism of Transition-Metal-Catalyzed Transfer 
Hydrogenation with Isopropanol. 
M-H 
The mechanism of the metal-hydride mediated transfer hydrogenation may 
involve direct coordination of the substrate to the metal center (the inner sphere 
mechanism) or hydrogen bonding and dipolar interactions of the substrate with two 
different sites of the catalyst (metal-ligand bifunctional catalysis, outer sphere 
mechanism) depending on the structure of the ligand.20a. 27. 33 In the inner sphere 
mechanism, the metal may form a monohydride (MH) or dihydride (MHz) species 
depending on the metal. It has been proven via deuterium experiments that rhodium- and 
iridium-catalyzed reactions follow the monohydride pathway34 where ruthenium follows 
the dihydride pathway.27 
33 Noyon, R.; Yamakawa, M.; Hashiguchi, S .  J. Org. Chem. 2001,66,7931 
3P Pamies, 0.; Backvall, J. E. Chem. Eur. J .  2001, 7, 5052. 
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Figure 1.9: Non-Classical Metal-Ligand Bifunctional Mechanism of Transfer 
Hydrogenation with Isopropanol. 
7 '? Base 
M':y-H 
7 
:N-M 
R -HX 16e 
Regardless of the metal species, the conventional (inner sphere) mechanism of 
transition-metal-catalyzed transfer hydrogenation involves & i t  coordination of the 
33 . substrate to the metal. Flgure 1.8 outlines the mechanism of transfer hydrogenation with 
isopropanol and transition metal, in which X represents a halide. Base is required to 
generate the isopropoxide ion, which coordinates to the metal and then undergoes P- 
elimination to generate the metal hydride (15) and acetone. Coordination of the substrate, 
which, in this example, occurs through the carbonyl group, to the metal center followed 
by a hydride transfer gave intermediate (17). Hydrogenolysis of (17) gives the reduced 
product (18) and the catalyst goes back to the start of the cycle.33 
The non-classical (metal-ligand bifunctional catalysis, outer sphere) mechanism 
occurs with diamine catalysts such as Ru-(S)-XylBINAP-DAIPEN (Figure 1.9), which 
Noyori terms a metal ligand bifunctional catalyst.27 Theoretical calculations along with 
experimental findings suggest that the hydrogenation of the carbonyl group takes place 
via the six-membered ring transition state shown in Figure 1.9(a).'~ The 18-electron metal 
hydride complex is regenerated by dehydrogenation of isopropanol with the 16-electron 
metal amide via the same six-membered ring. The reaction involves the participation of 
both the metal and the ligand. Neither the substrate (carbonyl) nor the hydrogen donor 
(isopropanol) interacts directly with the metal center. The reduction occurs in the outer 
sphere of the metal hydride complex.'3 
1.3.3 Summary of Asymmetric Transfer Hydrogenaton 
Transfer hydrogenation occurs via two major pathways, the Meerwein-Ponndorf- 
Verley (MPV) pathway, where a metal hydride is never formed and the hydridic pathway, 
which occurs via the formation of a metal hydride. Within the hydridic pathway, there are 
two mechanisms: the conventional metal hydride mechanism (inner sphere), which 
involves direct coordination of the substrate with the metal and the metal-ligand 
bifunctional mechanism (outer sphere), where the substrate doesn't directly coordinate to 
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27 . the metal center. Llke in asymmetric hydrogenation, asymmetric transfer hydrogenation 
(ATH) transforms prochiral substrates to their reduced products in high yield and 
enantiomeric excess with the help of c h i d  ligands. 
There are many advantages associated with the asymmetric transfer hydrogenation 
reaction. It is a cheaper, safer and the yield and enantiomeric excess are comparable to 
that obtained from gaseous hydrogenation. Extensive effort is given to this area in organic 
synthesis due to the low cost and favorable properties of the hydrogen donor as well as 
the operational simplicity.20b 
1.4 Conclusion 
Asymmetric catalysis is a powerful tool in organic synthesis.33 Since its modest 
beginning in the 1960s, this field in organic chemistry has revolutionized the way 
synthetic organic chemists operate. Continuous effort is given to this area and many 
catalysts have been developed to improve the reactivity and enantioselectivity of the 
reaction to practical levels. 
Lately, new catalysts are being used in transfer hydrogenation, which often result 
in similar yield and enantioselectivity without the danger associated with the high 
pressure in gaseous hydrogenation. Several catalysts have been reported to be efficient in 
the asymmetric transfer hydrogenation of carbonyls, imines, and activated olefins like 
conjugated carboxylic acid and amino acid derivatives. However, there has not been any 
example of asymmetric transfer hydrogenation of an allylic compound. In this thesis, the 
synthetic and mechanistic aspects asymmetric transfer hydrogenation of allylic alcohols 
with ruthenium catalysts will be presented. 
CHAPTER 2: CHIRAL METHOD DEVELOPMENT 
2.1 Introduction 
At the early stage of this project, the enantiomeric purity was determined by 
derivatizing the reduced product (citronellol) with (S)-Mosher acid chloride, [S-(+)- 
methoxy-trifluoromethylphenylacetyl chloride], followed by chromatographic separation 
of the diastereomers. The diatereomers, S-Mosher-S-citronellol and S-Mosher-R- 
citronellol, were separated using a Daicel Chiralcel OJ HPLC column. This method was 
used at the beginning of the project but was considered expensive and unreliable due to 
the discrepancy obtained when coupled the racemic citronellol with the S-Mosher acid 
chloride; a 5 - 6 % diastereomeric excess (de) was obtained. Searching for a cheaper and 
more reliable chiral separation method became our first priority. 
2.1.1 Background 
Chirality is now a major theme in the discovery, development, and 
commercialization of new drugs. About half of drugs in use are c h i d  and about 25% of 
them are administered as pure enantiomers due to their chemical and pharmacological 
behavior.35 It is well know that in most cases the pharmacological activity is restricted to 
one of the enantiomers (eutomer) whereas the other enantiomer (distomer) has either no 
activity or can even be toxic (Table 2 . 1 ) . ~ ~  For example, in the late 1960s thalidomide 
(softenon@) was found to be a seriously teratogenic for causing birth defects in more than 
10,000 babies as it was prescribed for morning sickness to pregnant women.37 It was later 
35 Gubitz, G.; Schmid, M. G. J. Chromatogr. A 2008,1204, 140. 
36 Stevenson, D.; Wilson, I. D. RecentAdvances in Chiral Separation, Plenum Press: New York, 1990. 
37 http://www.chem.yale.edu/-cheml25/125/thalidomide/thalidomide.html 
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discovered that these anomalies were due to a single enantiomer of this chiral molecule. 
Consequently, the separation of enantiomers has become a major field in pharmaceutical 
industries. 
Table 2.1: Differences in Pharmacodynamic ~ c t i o n . ~ ~  
Isomers Producing Different types of Toxicity 
Chemical Effect of (+)-isomer Effect of (-)-isomer 
Thalidomide Teratogenic Nonteratogenic? 
- 
Peripheral effect least 
Hyoscyamine Most potent (ten-fold) potent 
l~somers Producing Different types of Therapeutic Effect 
I ~ y d r o x ~ - ~ - m e t h y l  Analgesic morphinan Antitussive 
Bupivacaine Local anaesthetic & Local anesthetic 
vasoconstrictor 
One Isomer Responsible for The Therapeutic Action, The Other Toxic 
Therapeutic effect Toxic effect 
Timolol 
Reduction of P-Andrenergic antagonism intraocular pressure (S-form) (RS-forms) 
Pepticides in insects Inhibition of neurotoxic 
Dialkylphosphates (no therapeutic esterase leading to 
benefict) neurophaty ((-)form) 
It is worth noting that racernic thalidomide  halomi mid^) in combination with 
dexamethasone is now one of the best treatments in the market for multiple myeloma 
(bone marrow cancer). It is also used to treat and prevent the debilitating and disfiguring 
skin sores caused by erythema nodosum leprosum (ENL), an inflammatory complication 
of leprosy.38 Thalidomide is being sold as a chiral mixture because it racemizes in the 
body. Therefore, it passes the Food and Drug Administration (FDA) guidelines for the 
development and commercialization of chiral drugs.39 It is preferred that new drugs only 
contain the active enantiomer when it is demonstrated that it is not converted to the 
distomer in vivo or during storage. For the registration procedure, the FDA requires a 
chiral method capable to qualify the distomer from the eutomer. As a result, more 
industries are dedicated to the separation of stereoisomers. 
2.1.2 Major Types of C h i d  Techniques 
There are many techniques for the analysis and separation of chiral molecules. 
Some non-chromatographic techniques include polarimetry and nuclear magnetic 
resonance (NMR) spectroscopy. The disadvantages of these techniques are the need of an 
enantiomerically pure reference sample and the enantiomers are not separated during the 
analysis. The most popular types of c h i d  techniques are gas chromatography (GC) and 
high performance liquid chromatography (HPLC). These techniques are preferred because 
pure enantiomers are not required and the separation of the enantiomers does take place.40 
Furthermore, these chromatographic techniques can be used to prepare enantiomerically 
pure molecules. 
38 http://www.thalo~d.corn/ 
39 http~/www.fda.gov/cder/guidance/stereo.hm 
" Anderson, S.; Allenmark, S. G. J. Biochern Biophys. Methods 2002,54, 1 1  
2.1.3 Cltiral HPLC as a Separation Technique 
Chiral HPLC is one of the best and most widely used chiral separation techniques. 
The separation can be direct, which involves the use of a chiral stationary phase (CSP) or 
c h i d  mobile phase (CMP), or indirect, which involves derivatization of the enantiomers 
prior to the analysis.40 The separation of enantiomers over the CSP is well understood. 
The enantiomer that forms the strohger association with the CSP will be the more 
strongly retained, thus, it will have a longer retention time ( t ~ ) .  The enantioselectivity (a) 
of the c h i d  chromatography system is then expressed as the ratio of the retention factors 
of the two enantiomers (Eq. 2.1). 41, 42 
Eq. 2.1 
a = (~R(R) - W(~R(S) - to) 
where to = void time and t~ = retention time of the enantiomers R and S. 
This ratio may sometimes be close to the value of the thermodynamic 
enantioselectivity of the association of the CSP with the enantiomers. On the other hand, 
the more polar mobile phase reduces the t~ of the enantiomer that forms the stronger 
association with the CSP. Therefore, the effective enantioselectivity of the 
chromatographic system will be proportional to the ratio of the enantioselectivity of the 
association processes in the stationary and mobile phases (Eq. 2.2). 41,42 
There are many other factors that can affect the retention, resolution, and 
stereoselectivity of chiral compounds. Some of these factors include temperature, flow- 
41 Davankov, V. A.; Kurganov, A. A.; Ponomareva, T. M. J.  Chromatogr. 1988,452,309. 
42 Kazakevich, Y.; LoB~tto, R. HPLC for Pharmaceutical Scientists, John Wiley & Sons: Hoboken, New 
Jersey, 2007. 
rate, mobile phase composition, and pH. For example, some enantiomers contain amino 
or hydroxy groups that might hydrogen bonds with the stationary phase; the pH of the 
mobile phase can increase the solvation of the enantiomers, thus, enhance the peak shape 
42, 43 
and t ~ .  A similar effect can be obtained by increasing the temperature of the column, 
increasing the flow-rate, or increasing the polarity of the mobile phase. Although the pH 
and temperature have a great effect on the peak shape, they have a small effect on the t ~ .  
The flow-rate and the mobile phase composition have greater effects on the t ~ .  Steric 
repulsion and the pH, ion strength and temperature of the mobile phase all affect the 
resolution of enantiomers. 
Despite the great understanding of the chiral HPLC system, a successful chiral 
separation is often not predictable based on the CSP structures. Finding the right CSP for 
the separation of enantiomers can be very difficult. In most cases, the chiral separation is 
obtained by trying various CSPs. One can understand the interactions among the 
enantiomers, the CSP, and the mobile phase, but still has difficulty of obtaining a 
successful enantioseparation. The decision of choosing the right CSP relies mostly on 
empirical data or by using predictive empirical rules that have been developed based on 
empirical structures. 
2.1.4 Chiral GC as a Separation Technique 
Chiral GC is another efficient and reliable technique for the separation and 
quantitation of enantiomers and dia~tereomers.~~ It is mainly used for volatile and 
thermally stable solutes. In general, the retention time (tR) of the solute is determined by 
43 Kealey, D.; Haines, P. J. Analytical Chemistry, BIOS Scientific Publishers Ltd.: Oxford, 2002. 
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the solute's boiling point; except where there are specific interactions with the stationary 
phase, which is the basis of chiral separation. Just as in the chiral HPLC, enantiomers can 
be separated by either direct or indirect methods in the GC. The indirect methods involve 
derivatization of the enantiomers to diastereomers using a homochiml reagent, followed 
by separation on an achiral GC column. The direct separation is the most desired method; 
the success relies on direct separation of the enantiomers using a c h i d  stationary phase 
(CSP). In this method, the enantiomers form rapid and reversible transient diastereomers 
with the CSP. It is a straightforward method and avoids all problems associated with the 
chiral derivatization process in the indirect method. Except for very polar compounds, 
such as alcohols, amines, and acids, no pre-column derivatization is required to separate 
enantiomers. 
Based on the interaction with the enantiomers, the CSPs are divided in three 
major categories: 1) diamine and amino acid derivatives which form hydrogen bonds with 
the analytes; 2) chiral metal complexes which coordinate to the analytes; and 3) 
cyclodextrin (CD) derivatives which separate enantiomers by dipole-dipole interations, or 
by forming an inclusion complex with the analytes. Among the three types of chiral 
selectors, the CD derivatives remain the most popular CSPs in enantioselective GC 
(Figure 2 . 1 ) . ~ ~  
44 He, L.; Beesley, T. E. J .  Liq. Chrom. & Rel. Techn 005,28, 1075. 4+ 
Figure 2.1: Application of Different GC Chiral Stationary Phases from 1/01 to 7/04. 
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Figure 2.1 summarizes a survey on publications discussing separation of 
enantiomers with various c h i d  capillary GC.44 From January 2001 to July 2004, the use 
of chiral metal stationary phases has dramatically diminished; the amino acid derivatives 
CSPs are limited to specific applications; but the CD derivatives account for nearly 90% 
of successful enantiomeric GC separations. 
Chiral stationary phases based on CD derivatives remain popular in recent years 
due to their versatility. Their applications cover almost all the fields where other CSPs are 
applied.45 There are many types and sizes of CSPs based on CD derivatives. Depending 
on the cavity size and percentage of cyclodextrins (a, P, or y), different enantiomeric 
selectivities are obtained. It is also believed that the type, the site, the percentage, and the 
degree of substitution on positions (2-, 3-, and 6-position of glucose unit of CD) of the 
45 a) Nokihara, K.; Gerhardt, J. Chirality, 2001, 13 (8), 431; b) Spanik, I.; Oswald, P.; Krupcik, I.; 
Bennica, E.; Sandra, P.; Amstrong, D. W. J. Sepn. Sci. 2002,25 (ln) 45; c)  Bayer, T.; Riemer, C.; Kessler, 
H. J. Pep!. Sci. 2001, 7,250. 
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substituents all influence the enantioselectivity of the CSP. Therefore, the synthesis of the 
CD derivatives must be carefully controlled and final structures must be fully 
characterized to avoid reproducibility A list of CD derivatives and their 
recent applications are summarized in Table 2.2." 
Table 2.2: Derivatized Cyclodextrins and their Recent Applications in Chiral GC." 
r 1 
I GC chiral selector 1 
Hexakis (2.6-di- 
Opentyl-3-0- 
trifluoroacety1)-a- 
cyclodextrin 
Hexakis (2,3,6-tri- 
0-penty1)- 
Coated 
or 
bonded 
Coated 
Coated 
1 n = 6: alphacyclodextrin n = 7: beta-cyclodextrin n = 8: gamma-cyclodextrin 
, 
Zhiraldex A- 1 ASTEC 
ipodex A Macherey- 
Nagel I - 
Application 
x-Ketoester 
iydrogenation 
46 a) Schurig, V. J. Chromntogr. A 2001,906 (1-21,275; b) lunge, M.; Konig, W. A. J. Sepn. Sci. 2003.26, 
1606; c )  Jaus, A.; Oehme, M. J. Chromtogr. A 2001 905,59; d) Chena, G.; Shi, X .  Anal. Chim. Acta 
2003,498, 39. 
3eptakis (2,3-di- Coated 1 p-DEX325 1 SUPELCO 1 Lactone thio, thiono, 1 
Heptakis (2,3-di- 
O-ethyl-6- 
9-tea- 
butyldimethylsilyl) 
3-cyclodextrin 
Heptakis (2,3-di- 
O-acetyl- 
5-0-tea- 
butyldimethylsilyl) 
Coated 
Coated 
STEC 
&W 
kientific 
vlacherey- 
Jagel 
lestek 
3GB 
ba lp ik  
Restek 
MeGA 
SUPELCO 
Restek 
Iithioderivatives 
3icyclic y-lactone 
1-Butyrolactone 
ierivatives 
I-Irones 
'CBs 
Merpene 
3icycloheptane 
1-HCHs 
?ITS 
fletolachlor 
'01 ychlorinated 
Bipyrrole 
Sesquiterpenes 
Essential oils 
bfonoterpenes 
Sulfoxides and sulfinat 
:sters 
1,2-0-isopropylidene- 
sn-glycerol 
Flovour 
Secondary alcohols 
Sex pheromone 
Positional isomers 
Pesticides 
Fragrances 
Methyl 
dihydrojasmonates 
Monoterpene, 
Chiral alcohols 
3-Hydroxy acids 
Positional isomers 
Essential oils 
Lactone thio, thiono, 
dithioderivatives 
8, y-lactones 
Sex pheromones 
3-Hydroxy acids 
Aroma 
:oated 
Ioated 
:oated 
Bonded 
Heptakis (2,6-di- 
:hira ldex B- 
'A 
XDEX-B 
:p- 
:yclodextrin 
I- 
!,3,6-M-19 
I-DEX 120 
lyclodex-B 
Iydrodex-P- 
'M 
tt-PDEXm 
Jhirasil-DEX 
JB 
Jhirasil-P- 
]ex 
Coated 
ASTEC 
SGE Ltd, UK 
VarianKhro 
m- 
Pack 
SUPELCO 
J&W 
Scientific 
Macherey- 
Nagel 
Restek 
VarianIChro 
mPack 
Restek 
soprenoids 
ting-bonded a-amino 
icids 
Jhiral acids 
h i n o  acid derivatives 
Sex pheromone 
rerpenes 
Mandelates and its 
malogs 
kni t ine  derivative 
PCBs 
Glucopyranosides 
Polychlorinated 
substances 
Quinolizidine 
Furan derivatives 
Odorants 
Ketones 
a-Ketoester 
hydrogenation 
Tartaric acid 
Sex pheromones 
Hydroxy acids 
Amino acid derivatives 
Curtisians 
Essential oil 
Positional isomers 
Monoterpenes (aroma) 
Fragrance 
a-Hydroxy fatty acids 
PCBs 
CTTs 
Diterpenes 
Terpenes 
Aliphatic hydrocarbons 
Aryl- and 
heteroaqlcarbinols 
Sex pheromones 
Bonded Heptakis (2,3,6-tri- I r 7 0-methyl)- P-cyclodextrin 
Heptakis (2,3,6-tri- 
O-tert- 
butyldimethylsilyl) 
- 
P-cyclodextrin 
Heptakis (2,3,6-tri- 
0-ethyl)- 
P-cyclodextrin 
. 
cyclodextrin 
Octakis (bis- 
tertbutyldimethylsi 
1~1)- 
y-cyclodextrin 
Octakis (2,3-di-0- 
acetyl-6- 
O-tert- 
butyldimethylsilyl) 
- 
y-cyclodextrin 
Octakis (2.6-di-0- 
methyl-3- 
0-penty1)-y- 
cyclodextrin 
Octakis (2,6-di-- 
pentyl-3- 
0-trifluomacety1)- 
y-cyclodextrin 
Octakis (2,6-di-0- 
pentyl-3- 
0-propiony1)-y- 
cyclodextrin 
Octakis (2,3,6-tri- 
0-methyl)- 
y-cyclodextrin 
Zoated 
Eoated 
Coated 
Coated 
Coated 
Coated 
Coated 
Coated 
Coated 
Chirasil-p- 
Dex 
BGB-172 
Chiraldex B- 
PH 
Chiraldex G- 
TA 
Chiraldex G- 
PN 
SUPELCO 
Zestek 
- - 
ASTEC 
ASTEC 
SUPELCO 
SGE Ltd, UK 
Racemic-conglomerate 
Crystallization 
PCBs 
Pesticides 
Methyl-branched 
alcohol 
and acids sulfur- 
containing 
aroma 
Thiazolinecarboxylates 
PCBs 
Metalaxyl 
Branched hydrocarbons 
Sesquiterpene 
Glucopyranosides 
(aroma) 
Sulfoxides and sulfinate 
esters 
Epoxides 
~"bstituted carbocyclcs 
Sulfoxides and sulfinate 
esters 
Bicyclic y-lactone 
Alkaloids, 
herniterpenoids 
Chlodane 
y-cyclodextrin 
Octakis (3-0- 
butanoyi2,6- 
di-0-penty1)-y- 
cyclodextrin 
Octakis (2,3,6-tri- 
I 
Octakis (2,3-di-0- 
pentyl- 
6-0-methyl)-y- 
cyclodextrin 
?oated 
Bonded 
- 
Coated 
Lipodex-E 
Chiraldex G- 
BP 
Pesticides 
Macherey- 
Nagel 
ASTEC 
Chirasil-y- 
DEX 
Cyclic P-ketoesters 
Amino acids 
Flavor compounds 
Sulfoxides and sulfinate 
esters 
Lactones 
Insecticides 
Essential oils 
Anesthetics 
Halodiether B 
Halogenomethanes 
Isoprenoids 
Homoterpene esters 
Chiral alcohols 
Sex Pheromones 
As shown in Table 2.2 the CD derivatives CSPs are applied in the separation of a 
broad range of chiral molecules including essential oils, flavours and fragrances, 
alcoholic beverages, clinical chemistry, terpenoids, and pesticides. For example, volatile 
chiral sulfoxides, which are important bioactive compounds, are easily separated with 
heptakis(2,2-di-O-pentyl-3-trifluoroacetyl)--cyclodexrin (DPTFA - GCD).~' Mandelate 
analogs, which are important intermediates in pharmaceutical chemistry, are separated on 
both heptakis(2,3,6-tri-0-methyl)-P-cyclodextrin (PMBCD) and heptakis(2,6-di-0-nonyl- 
3-0-trifluoroacetyl-P-cyclodextrin (DNTBCD).48 Both coated and bonded PMBCD 
phases are suitable for the separation of saturated chiral aliphatic hydrocarbons, 
geometrical isomers of furan derivatives, positional isomers of xylenes and 
dimethylnaphthalenes, aryl- and heteroarylcarbinol, and a-hydroxyl fatty acid esters.49 
The octakis(3-O-butanoyl-2,6-di-n-pentyl)-y-cyclodextn phase is extremely useful in the 
separation of chiral halogenomethanes and various chlorinated and fluorinated ethers 
(inhalation  anesthetic^).^^ Therefore, CD based CSPs are classified as the most powerful 
tool in GC for separation on enantiomers. 
2.1.5 NMR in Chiral Analysis 
Nuclear Resonance Magnetic (NMR) spectroscopy is one of the most important 
methods used to determined optical purity of different classes of compounds. Although it 
is easily accessible, the NMR does not differentiate enantiomer~.~' Derivatization with a 
pure chiral auxiliary reagent to produce diastereomers must be performed prior to 
analysis. The chemical shifts of the diastereotopic nuclei will be different, which under 
the ideal condition results in baseline separation. Integration of the S and R diastereotopic 
nuclei leads directly to the estimation of enantiomeric purity. 
One type of chiral auxiliary agent used in NMR is the c h i d  lanthanide shift 
reagents. The lanthanide forms diastereomeric complexes in situ with the substrate 
enantiomers and may be used directly.s2 There are many lunds of lanthanide shift 
47 Aderson J. L.; Ding, J. McCulla, R. D.; Jenks, W. S.; Armstrong, D. W. J. Chromatogr. A 2002,946, 
197. 
48 
49 
Nie,M. Y.;Zhou,L. M.; Wang, Q.  H.;Zhu,D. Q.Ana1. Sci 2001,17(10), 1183. 
a) Meierhemich, U. J.; Nguyen, M. J.; Barbier, B.; Brack, A.; Thiemann, W. H. P. Chirality 2003.15, 
S13. h) Kasai, H. F.; Tsubuki, M.; Takahashi, K.; Shiiao, M.; Matsumoto, Y.; Honda, T.; Seyama, Y. J. 
Chromatogr. A 2002,977,125. c) Pivovar, A. M. K.; Holman, T.; Ward, M. D. Chem Muter. 2001,13, 
3018. d) Uray, G.; Stampfer, W.; Fabian, W. M. F. J. Chromatogr. A 2003,992, 151. e) Tokamolthom 1.; 
Chen, S. T.; Jeyasshoke, N.; Krisnangkura, K. Anal. Chirn. Acta 2002,465,299. 
M 
a) Crassous, J.; Jiang, Z.; Schurig, V.; Polavarapu, P. L. Tetrahedron: Asym. 2004,1S, 1995; h) cf. 46a; 
C) Schurig, V.; Schmidt, R. J. Chromatogr. A 2003, IWO, 311. 
51 
52 
Dufrasne, F.; Gelbcke, M.; Galanski, M. Spectrochimica Acta Pan A 2006,65,869. 
Parker, D. Chem Rev. 1991,91,1441. 
reagents, the most common ones are shown in Table 2.3. Addition of lanthanide shift 
reagent to an organic compound results in the resolution and the chemical shift of the 
enantiomeric signals move to lower frequencies. The lanthanide forms a weak addition 
complex with a large variety of organic compounds (alkenes, arenes, allenes) that is in 
fast exchange with the unbound organic substrate. This fast exchange results in line 
broadening of the signals, which makes it often preferable to acquire spectra on a 100- 
MHz instrument rather than a 500-MHz instrument where line broadening is 25 times 
more severe.s2 The line broadening represents a major disadvantage in this method. Even 
when special care is taken in the data acquisition (use of dry shift reagent, use of 
Gaussian line narrowing methods and base-line correction routines), the % error may be 
as high as 10% especially when the ee is >90%. 
Nuclear magnetic resonance (NMR) spectroscopy is based on the net absorption 
of energy in the radiofrequency region of the electromagnetic spectrum by the nuclei of 
certain elements in a molecule. All nuclei are assigned a spin quantum number, I, on the 
basis of the number of protons and neutrons in the nucleus. The number of permitted 
orientations in space that can be adopted by a nucleus subjected to a magnetic field is 
given by (21 + 1). For I = ?h, two orientations or energy levels are possible. Therefore, 
nuclei with even numbers of both protons and neutrons, for example I2c, 160, and 3 2 ~ ,  
have a spin quantum number of zero, no spin angular momentum, cannot give an NMR 
spectrum; where nuclei with a spin quantum number of ?h, including proton, carbon-13, 
phosphorus-31 and fluorine-19, will give an NMR spectrum.43 Any nucleus capable of 
giving an NMR spectrum can be used to identify the structure and optical purity of 
organic compounds. However, because 'H and I3c are the most widely studied spectra, 
they remain the most p o & u  tools for the determination of chiral purity. 
Table 2.3: Common Chiral Lanthanide Shift ~ea~ents .5 '  
Structure of L in LnL3 I Lanthanon Abreviationa I 
0- 
R = CF, 
R = C3F7 I Ytterbium (Yb) I 
0- 
I I 
'pvc = pivaloy-dcamphorato; tfc = trifluorohydroxymethylene-d-camphorato; 
Europium (Eu) 
Praseodymium (Pr) 
Ytterbium (Yb) 
hfc = heptafluorohydroxymethylene-d-camphorate; dcm = dicamphoyl-d-methanato. 
EuFtfc13 
Pr[tfcI3 
Yb[tfc13 
Europium (Eu) 
Praseodymium (Pr) 
Nuclei of a particular element that are in different environments generally 
experience slightly different applied magnetic field strengths due to the shielding and 
Eu[hfc]3 
Pr[hfcI3 
deshielding effects of nearby electrons. Consequently, their resonance frequencies vary 
and each frequency is defined by a characteristic chemical shift value. On the other band, 
the chemical shift of a particular element, whether chiral or achiral, remains unchanged in 
similar environment. After derivatization. the introduction of a second chiral center 
changes the environment of the first chiral center along with some neighboring 
(diastereotopic) elements in the same molecule. As a result, two different chemical shifts 
may be obtained for the diastereotopic nuclei. For example, Figure 2.2 and Figure 2.3 
show the proton and carbon NMR spectra of N-(((1R,5S)-6,6-dimethylbicyclo[3.l.l]hept- 
2-en-2-y1)methylene)-1-phenylethanarnine, 22, (Scheme 2.1)." 
Scheme 2.1: Reaction of 1-phenylethylamine (21) with the C h i d  Derivatizing Agent 
(CDA) (-)-mytend (20). 
(CDA) (-)-myrtena 1-pheny ethy am ne 
20 21 
Three samples of 1-phenylethylamine 21 were prepared in three different ratio of 
R:S enantiomers as follows: (a) 50:50, (b) 33.4:66.6, and (c) 14.435.6. After 
derivatization with (1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-ene-2carbaldehyde, 
commonly known as (CDA) (-)-myrtenal 20, the resulting diastereomers were analyzed 
by proton and carbon NMR. In the proton NMR (Figure 2.2), the spectral region of the 
imine proton (7.88 ppm) is shown and the diastereomeric ratios are found very close to 
the enantiomeric values: (a) 50.5:49.5, (b) 34.3:65.7, and (c) 15.7534.3. In the carbon 
NMR (Figure 2.3), the spectral region of C3=N-C (159.C~161.7 ppm) and C=N-CI 
(67.8-70.5 ppm) are shown. The ratios are also found to be consistent with the expected 
values: (a) 50.3:49.7 for C3 and 49.5:50.5 for C1; (b) 34.5:65.5 for C3 and 34.3:65.7 for 
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C1; and (c) 15.1:84.9 for C3 and 15.8:84.2 for C1. Better baseline resolution occurs in 
the "C experiments. 
Figure 2.2: Proton NMR of N-(((1R,5S)-6,6-dimethylbicyclo[3.l.l]hept-2-en-2- 
y1)methylene)- 1-phenylethanamine (22).5L 
Figure 2.3: Carbon NMR of N-(((lR,5S)-6,6-dimethylbicyclo[3.l.l]hept-2-en-2- 
y1)methylene)-1-phenylethanarnine (22)." 
Nuclear magnetic resonance (NMR) spectrometry also has its disadvantages. 
Resolution of the diastereotopic protons is not always obtained. In the above example 
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with 1-phenylethyamine, complete baseline separation was not achieved in the proton 
NMR (Figure 2.2); integration and determination of the R:S ratio was possible by using 
automated deconvolution and integration. Other examples in the same study resulted in 
complete overlap of the diastereotopic protons; I3c NMR was used in those cases, yet the 
difference in the expected ratios was as high as 6% in some cases. These errors are not 
only due poor resolution of the diastereotopic peaks; impurities in the chiral resolving 
agent combined with different reactivity of the enantiomers contribute to the discrepancy. 
2.2 Results and Discussions 
2.2.1 Derivatim'on with Mosher Acid Chloride and Diastereomeric Excess 
Determination by HPLC 
2.2.1.1 Introduction 
Mosher acid (a-methoxytrifluorophenylacetic acid) was first used by Harry S. 
Mosher as a chiral derivatizing agent in the late 1960s.~~ The chiral reagent reacts with 
alcohols or amines of unknown stereochemistries to form esters and amides. The absolute 
configuration of the ester or amide is then determined by proton NMR spectroscopy?4 To 
increase the reactivity of the Mosher acid, it is often converted to the acid chloride prior 
to the coupling  reaction^?^ 
One of the most popular methods used to determine the enantiomeric purity of 
citronellol is by derivatizing it with the (R) or (S)-Mosher acid chloride. In our case, the 
(R)-Mosher acid chloride was used (Scheme 2.2). The R-citronellyl-R-Mosher ester and 
53 Dale. J. A.; Dull, D. L.; Mosher, H. S .  J. Org. Chem.1969,34 ($9, 2543 
the S-citronellyl-R-Mosher ester are diastereomers, thus could be separated with an 
achiral column. However, attempts to separate these diastereomers using C18 columns 
were unsuccessful. We found that they could be separated using a chiral HPLC column. 
Scheme 2.2: Derivatization of Citronellol with R-Mosher Acid Chloride. 
R-mosher acid 
Et3N, 3 eq. 
Citronellol DMAP, 0.1 eq. 25 
23 CH& 
2.2.1.2 Results and Discussion 
Figure 2.4 shows the chromatogram of the citronellyl-Mosher esters. This 
particular example is from the reaction of a mixture of 41:59 R:S citronellol. After 
derivatization with R-Mosher acid chloride (3 equiv), a ratio of 43.1:56.9 of RR:RS 
diastereomers was obtained at 210 nm and 42.5:57.5 of RR:RS was obtained at 220 nm 
with a range of 3.7 to 4.8% difference from the expected ratio. This percent difference 
was even larger (6%)56 when 1.5 equiv of Mosher acid chloride was used in the 
derivatization reaction. 
'' Allen, D. A.; Tomaso, A. E. Jr.; Priest, 0. P.; Hindson, D. F.; Hurlburt, 1. L. J. Chern. Educ. 2008.85, 
698. 
'' Ward, D. E.; Rhee, C. K. Tetrahedron Lett. 1991,32 (49), 7165. 
56 Laquidara, J. M. Ph. D. Dissertation, Department of Chemistry and Biochemistry, Seton Hall University, 
South Orange, NJ, 2003. 
Figure 2.4: HPLC Chromatogram of Citronellyl-Mosher Esters. 
Chromatographic Conditions: Diacel Chiralpack OJ-H, 250 mm x 4.6 mm; 90: 10 
to 50:50, ethanol:hexanes, 0.6 W n ,  20 minute gradient; room temperature; 
210 and 220 nm. 
Although satisfactory baseline separation was obtained from the Diacel Chiracel 
OJ-H HPLC column, finding a better chiral method was still needed. The 5% to 6% 
difference was too high for our purpose since we were expected citronellol as high as 
98% ee from the transfer hydrogenation reaction. In addition, to reduce the discrepancy in 
the reactivity of the R and S enantiomeris of citronellol, a large excess (about ten equiv) 
of the pure (>99% ee) Mosher acid chloride would have to be used. That would require 
about 556 mg of the Mosher acid chloride for each reaction of 35 mg of citronellol. The 
cost of the Mosher acid chloride from Aldrich is $2921500 mg. Therefore each 
derivatization would cost over $324 for a more accurate result; or a minimum of $49 if 
only 1.5 equiv of the Mosher acid chloride is used, which gives a 6% difference. 
toluene, resulted in the decomposition of the starting material; the product was never 
obtained. Our initial work with oxalyl choride in refluxed methylene chloride were also 
unsuccessful. Maybe higher temperatures were damaging to the reaction. So we decided 
to conduct the reaction at room temperature following Nagasawa's procedure with neat 
oxalyl chloride.58a The problem with this procedure is that the product was obtained as a 
sluny; filtration of the sluny gave a yellow solid in very low yield. Using Wang's 
isolation procedure (see Section 2.2.2.3 (S)-Naproxen acid chloride was 
obtained as a white needle-shaped crystals in 88% yield. Subsequent treatment with 
citronellol gave the diastereometic esters, which were analyzed by NMR. 
Scheme 2.3: Derivatization of Citronellol with S-Naproxen. 
- 
- 
- c+ 
0 27 
H 3 C 0  neat rt H 3 C 0  
- m 
Step 2 
2.2.2.2 Results and Discussion 
Four different samples of citronellol were prepared in the following ratios of R:S 
enantiomers: (a) Aldrich racemic citronellol assumed to be 50:50, (b) 36.28:63.72, (c) 
14236 and (d) 6:94. All four samples were converted to the (S)-Naproxen ester and the 
resulting diastereomers were analyzed by I3c NMR (Table 2.4). The proton NMR was 
not utilized because the (S)-Naproxen citronellyl ester diatereomers completely overlap 
giving one set of signals. The carbon NMR mostly overlaps; but, four carbons gave 
partial to complete separation with the best separation occurring for C3 of the citronellyl 
chain, at 29.66 (R) to 29.7 (S) ppm (Figure 2.5). 
Table 2.4: Comparison of Standard Citronellol Samples (a, b, c and d) with the (S)- 
Naproxen Esters Results from I3c NMR. 
Integration of the two diastereomeric peaks of C3 in 29 is summarized in Table 
2.4 and Figure 2.6. The I3c NMR integration of C3 of the (S)-Naproxen citronellyl ester 
gave the following R:S ratios: (a) 49.5850.42, (b) 32.22:67.78, (c) 6.14:93.86, and (d) 
was difficult to integrate. The NMR result for sample (a) was in agreement with the 
standard racemic citronellol, but the % difference for sample (b) was 4.06% and 7.86% 
for sample (c). It was difficult to integrate sample (d) because there wasn't any baseline 
separation; the (R) signal was too small. These results indicate that the derivatization 
method with (S)-Naproxen followed by 13c NMR analysis is useful to determine up to 
36:64 R:S citronellol ratio. Any larger ratio would result in a % difference greater than 
Figure 2.5: I3c NMR Segment of Sample (b) [(S)-Naproxen Citronellyl Ester]. 
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Figure 2.6: Comparison of Standard Citronellol Samples (a, b, c and d) with their (S)- 
Naproxen Esters Results from I3c NMR. 
rn % (R)-Citronellol prepared 
This behavior was previously investigated in our group in the reaction of S- 
Naproxen acid with ~ec -~hen~ le thano l .~~  It was found that S-sec-phenylethanol reacts 4.5 
times faster than R-sec-phenylethanol with S-Naproxen. Therefore, incomplete reaction 
during derivatization leads to residual unreacted alcohol (R-sec-phenylethanol), which 
results in further discrepancy of the diastereomeric purity. It was then concluded that the 
optimum amount of the resolving agent needed was ten equivalents. 
2.2.2.3 Conclusions 
Although S-Naproxen is about 100 times cheaper than the Mosher acid chloride, it 
didn't meet our needs. Our NMR results show large discrepancies between the standard 
citronellol enantiomers and the S-Naproxen diastereomers. The higher the enantiomeric 
excess, the greater the dicrepancy. In addition, it was difficult to obtain a signal for the 
minor diastereomer when the ee was >95%. In the future, however, it may be possible to 
obtain better results if we follow improvements suggested by Li ~i~~ and use more 
concentrated samples and long acquisition times to increase the I3c NMR sensitivity. 
However, this method was rejected and the desire to find a better and cheaper c h i d  
separation method was still present. We wanted to find a method capable of determining 
enantiomeric excess greater than 95% ee with less than 5% difference. 
59 Li, L. Ph. D. Dissertation, Department of Chemistry and Biochemistry, Seton Hall University, South 
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2.2.3 Direct Separation on Chiral GC Column 
2.2.3.1 Introduction 
Direct chromatographic separation of enantiomers is the most desirable method by 
most analytical chemists.44 In most cases the method is faster and more reliable than 
performing a derivatization. As mentioned above, derivation of citronellol with Mosher 
acid chloride and Naproxen results in various levels of error and were not reliable at high 
enantiomeric excess. Therefore, it was decided to determine the ee of the crude citronellol 
using a c h i d  GC column without derivatization. 
2.2.3.2 Results and Discussion 
To validate the chiral GC method, five standards of citronellol were analyzed. 
Three samples were prepared and the racemic and enantiomerically pure S-citronellol 
from Aldrich were also analyzed which gave a total of five standards in the following 
ratios of R:S enantiomers: (A) racemic citronellol assumed to be 50:50, (B) 5.46:94.54, 
(C) 3.48:96.52, (D) 2.43:97.57, and (E) S-citronellol (sold as >98% ee) 1:99 (Table 2.5). 
All samples were prepared in three different concentrations in methanol 
(0.01 M, 0.02 M and 0.1 M) and the % ee reported is the average of three data points. 
These concentrations were selected based on our reaction concentration (0.01 to 0.1 M), 
but, excellent baseline separation can be obtained for racemic citronellol at 1 M 
concentration (Figure 2.8). The chiral GC results for the standard citronellol samples (A, 
B, C, D and E) are summarized in Table 2.5 and a schematic representation of these 
results is shown in Figure 2.7. 
Orange, NJ, 2005. 
Table 2.5: Cornparaison of Standard Citronellol samples (A, B, C, D and E) with the 
Chiral GC Results. 
Figure 2.7: Comparison of Standard Citronellol Samples (A, B, C, D and E) with the 
Chiral GC Results. 
The ee found for the racemic citronellol is very close to the expected value, giving 
a difference of less than 0.1%. The S-citronellol from Aldrich has an optical purity of 
298%. Our chiral GC method revealed 97.91% (S), with a difference of -0.09%. Sample 
B was found to have a difference of 0.08% and sample C 0.1%. The largest % difference 
was obtained from sample D, which was 0.45%. In summary, the ee found for all the 
purchased and prepared standards using our chiral GC method were very close to the 
expected values. In addition, the cost of a RT-BetaDEXsa column is less than $700. 
However, it is recommended to use proper care to extend the life of this column. For a 
short-term standby mode, it is suggested to leave the column in the GC with the carrier 
gas flow on at an oven temperature of 100 - 150 "C. For long-term storage, it is 
recommended to remove the column from the GC and store away from strong light6' 
Figure 2.8: Chiral GC of 1 M Citronellol in Methanol. 
Chromatographic conditions: RT-BetaDEXsa column, 30 m x 0.32 rnm ID x 0.25 mrn; 
inlet, split mode (50:1), 150 "C; column, isothermal 80 "C, He flow 30 mumin, 15 psi, 
120 min; detector 150 "C; 10 p1 injection. 
2.3 Conclusions 
Three chiral methods were tested in the separation of R and S enantiomers of 
citronellol. Our validation studies reveal that direct separation using a chiral GC column 
was the most reliable method. The RT-BetaDEXsa GC column gives baseline separation 
for citronellol of 298% ee with less than 0.5% error. This method is faster, cheaper and 
more reliable than doing derivatization with either Mosher acid chloride or S-Naproxen. 
Derivatization with the Mosher acid chloride gave a moderate HPLC baseline 
separation for the diastereomers with a 5 - 6 % difference when using racemic citronellol. 
We did not investigate how this percent error would change at higher R:S or S:R ratios of 
citronellol. However, this method was abandoned due to the high cost of the Mosher acid 
chloride, $29'21500 mg. 
S-Naproxen is a cheaper derivatizing agent; it is nearly 100 times cheaper than the 
Mosher acid chloride. The 13c NMR of the diastereomers of the racemic citronellol gave 
good baseline separation with a 0.42% difference. However, this error got larger at higher 
R:S citronellol ratios. A 7.86% difference was obtained from a 14:86 R:S citronellol 
mixture and this method failed to give any result for a 6:94 R:S citronellol mixture. 
As shown above, the chiral GC method gave excellent baseline separation for 
citronellol of 298% ee with a difference of 0.09%. The largest difference obtained with 
this method was 0.4596, which may be related to some measurement errors. The errors 
associated with umeacted citronellol or with different rates of reaction of the chiral 
auxiliary during derivatization were no longer a problem. This method is direct, fast and 
reliable. So it was decided to determine the enantiomeric excess of our reaction mixtures 
by c h i d  GC. 
CHAPTER 3: ASYMMETRIC TRANSFER HYDROGENATION OF ALLYLIC 
ALCOHOLS 
3.1 Introduction 
Assymetric transfer hydrogenation (ATH) is an alternate process of performing 
asymmetric hydrogenation of prochiral substrates in high yield and enantioselectivity 
without the danger associated with hydrogen gas. Most ATH reactions are conducted in 
the presence of IPA or formic acidhiethyl arnine mixtures as hydrogen donors, which 
eliminates the need for a pressure vessel. ATH is a safer, cheaper and an operationally 
simpler process. There have been many examples of transfer hydrogenation reactions in 
the literature. The reduction of ketones, aldehydes and imines are among the most 
common exampleszoas 25' 28' 31. 32, 61 and the reduction of a$-unsaturated acids are less 
common. '@ 6z Furthermore, there have been examples of transfer hydrogenation of 
allylic alcohols.63 However, those examples resulted in no enantioselectivity. 
Ruthenium catalyzed asymmetric transfer hydrogenation (ATH) of allylic alcohols 
is a novel reaction. The reaction was discovered in our research group by Joseph 
Laquidara while he was doing his Ph.D. with Prof. John R. Sowa. While attempting to 
isornerize geraniol to y-geraniol with the [RUC~~((S)-(-)-~O~BINAP)]~/N(C~H~)~ catalyst, 
instead of obtaining y-geraniol, citronellol was obtained in 27% yield and 50% ee. To our 
knowledge, this is the first example of asymmetric transfer reduction of an allylic alcohol. 
61 a) Ahn, K. H.; Ham C.; Kim, S. K.; Cho, C. J. Org. Chem. 1997.62.7047; b) Zassinovich, G.; 
Mestroni, G.; Gladiali, S. Chem. Rev. 1992,1051. 
62 a) Brown, J. M.; Bmnner, H.; Leitner, W.; Rose, M. Tetrahedron: Asym. 1991,2,331; 
b) Saburi, M.; Ohnuki, M.; Ogasawara, M.; Takahashi, T.; Uchida, Y. Tetrahedron Len. 1992,33, 
5783. 
Cadierno, V.; Francos, I., Girneno, J.; Nebra, N. Chem. Commun. 2007,2536. 
3.1.1 Project origin 
There has been some interest in our group to isomerize geraniol to y-geraniol and 
the thermodynamic concentration of geraniol to y-geraniol under various conditions has 
been investigated.56 For example, geraniol was converted to y-geraniol in 18% yield using 
catalytic amount of [RUCI~((S)-(-)-~~~BINAP)]~/N(C~H~)~ in MeOH at room temperature. 
At 45 "C, the amount of geraniol increased to 22%. However, as discussed above, in a 
neat reaction at 140 "C, the reduced product, citronellol, was obtained in 27% yield and 
50% ee (R) (Scheme 3.1). 
Scheme 3.1: First Example of Ruthenium Catalyzed Asymmetric Transfer Hydrogenation 
(ATH) of an Allylic 
RU(II)(S)-~O~BINAP 
MeOH 
geraniol 
gamma-geraniol 
18% yield at 20 O C  
22% yield at 45 O C  
RU(II)(S)-~O~BINAP 
Neat 
140 OC, 3 days 
citronellol 
27% yield, 50% ee (R) 
Soon after this initial result, extensive effort was put into the optimization of this 
reaction. Based on previous literature references, it was decided to use isopropanol as 
hydrogen donor and potassium hydroxide as base in the reaction. The focus of the 
optimization work was to find a good mtheniudligand catalyst system, as well as, the 
optimum temperature, which could result in higher yields and ee's. Table 3.1 summarizes 
the results of some of the ligands screened in this reaction. Using 0.01 M geraniol in 
isopropanol and a substratel[Ru(COD)C12]JKOH/ligand molar ratio of 10/1/2.1/2, it was 
demonstrated that (S)-tolBINAP (A, Figure 3.1) gave the best yield (95%) and 
enantiorneric excess (90% ee) (entry 5, Table 3.1). 
Table 3.1: Evaluation of Various Ligands in the ATH of GeranioLS6 
Entry" Ligand Time (h) % ~ o n v . ~  % Citronellol (% eec, Config.) 
31 (0) 
"0.01 M solution in PA,  (geranioV[Ru(COD)C1~]&OH/ligand molar ratio = 10/112.11 , 
b~~ yields measured on a DB-5 column (J&W Scientific, 15 m x 0.32 mm). 'ee analysis 
measured on the (R) Mosher ester on a Chiralcel 01-H column (Daicel, 250 mm x 4.6 
mm). *78% isolated yield by column chromatography. e98 % dihydrocitronellol formed, 
(geranioV[Ru(COD)Cl2]&OH/ligand molar ratio = 2/1/2.1/2). 
The reaction with (S,S)-iPrDUPHOS (B, Figure 3.1) went to 100% conversion but 
without regioselectivity (entries 7 and 8, Table 3.1). This ligand resulted in the reduction 
of the second double bond of geraniol to give dihydrocitronellol (3,7-dimethyl-octan-1- 
01). However, this result suggests that this ligand produces a more powerful catalyst 
which is able to reduce functionalized and unfunctionalized alkene groups. 
Figure 3.1: Ligands Used in Table 3.1 and Table 3.2.56 
to1 BlNAP 
A 
iPr DUPHOS 
B 
BlNAP 
DlOP PHANEPHOS Me DUPHOS Ef BPE 
Several substrates (Figure 3.2) were evaluated in this reaction using two of the 
most reactive ligands, S-tolBINAP and (S,S)-iPrDUPHOS (Table 3.2). It has been 
demonstrated that the allylic bond of several allylic alcohols (geraniol, nerol, 3-phenyl-2- 
buten-1-01) can be converted to their saturated alcohols in excellent yields (95 - 99 %) 
and moderate to good ee (72 - 93 %) with S-tolBINAP. Lower yields were obtained for 
geraniol and nerol with iPr-DUPHOS, but this catalyst was proven to be the best for 3- 
phenyl-2-buten-1-01. giving 99% yield and 93% ee. An a$-unsaturated carboxylic acid, 
was also converted to the reduced product in excellent yield, but in low enantioselectivity 
with both ligands. The reaction with 3-methylcyclohex-2-enone resulted in double 
reduction of the olefinic and the carbonyl groups in high yield with both ligands (97 - 98 
% yield), but the diastereoselectivity was significantly lower (4: 1, cis:trans) compared to 
what was obtained from gaseous hydrogenation (1:3000 ~is:trans).~ Lastly, the reduction 
of the double bond in trans-methylstilbene resulted in low conversion, only 18% in 24 h 
(entry 11, Table 3.2). 
Table 3.2: Transfer Hydrogenation with RuItolBINAP (A) and RuIiPrDUPHOS ( B ) . ~ ~  
.. .- 
9 23 cis (17, S,R) 
3-methylcyclohex-2- 
-.... 6 trans, (16, R,R) 
................................ 
10 enone 34 cis (8, S,R) 
9 trans (14, R,R) 
. . ......... 
11 trans-methylstilbene 24 (18) 18 (0) 
I I I I 
'0.01 M solution in P A .  lsubstratellRu~COD~C1~1fiOWlirrand molar ratio = 10111 
Entrya 
1 
2 
- .  , - 
2.1121. b~~ yields measuredwith a DB-5 column (J&W Scientific, 15m x 0.32mm). 'ee 
analysis of entries 1-4 measured on the (R) Mosher ester on an OJ-H column; ee analysis 
of entry 5 and 6 measured on the acetate on an OJ-H column; ee analysis of entries 7,8 
and 11 measured directly on an OJ-H column; ee analysis of entries 9 and 10 measured on 
the (R) Mosher ester where the ee of the cis isomer was measured by GC analysis on a 
DB-23 column (J&W Scientific, 15m x 0.32mm) and the ee of the trans isomer was 
measured by proton decoupled NMR. '2.5 equiv. of KOH per substrate was used. 
Ligand 
A 
. 
B 
Substrates 
geraniol 
Time (h) 
(% convb) 
2 (100) 
2 (100) 
% productb 
(% ee, config)" 
95 (90, R) 
- 
50 (80-84, R) 
Figure 3.2: Substrates Used in Table 3.2? 
2-pheny -2-buteno c ?-methy -2- 
ac d cyc ohexenone trans-methy st bene 
It is worth noting that the configuration of the products obtained from nerol and 
geraniol were consistent with the gaseous hydrogenation; but the result for 3- 
methylcyclohex-2-enone, which gave a very low stereoselectivity, clearly indicated that 
our system was different. Therefore, it was imperative to understand the mechanism of 
our system. 
3.1.2 Project Goals 
The main objective of this project was to understand the mechanism of this 
interesting and potentially useful rutheniundBINAP asymmetric transfer hydrogenation 
(ATH) reaction. To meet this objective, the effects of various hydrogen donors, including 
cyclic and chiral alcohols, at different concentrations and temperatures have been studied. 
The asymmetric transfer hydrogenation of a homoallylic alcohol, y-geraniol, has been 
conducted and compared to the result of the gaseous hydrogenation reaction. The effects 
of a commercial catalyst, [(S)-BINAPIRu(QC12, which may have a similar structure to 
our in situ-prepared catalyst@, has been investigated. In addition, we have studied the 
isomerization of geraniol in the absence of a hydrogen donor and with a deuterated donor. 
3.2 Results and Discussion 
3.2.1 Asymmetric Transfer Hydrogenation with Mixed Solvents 
Using the optimized conditions with 0.01 M geraniol with a 
substrate/[R~(C0D)C12]~IKOW(S)-tolBINAP molar ratio of 10/1/2/2, several solvents 
were screened for effectiveness in the ATH reaction. Since the purpose of the isopropyl 
alcohol (PA) is to transfer hydrogen in the reaction, we wanted to investigate the effects 
of different solvents while using P A  as a reagent. Thus, we added >I00 equiv of P A  to 
serve as the reductant. 
As shown in Table 3.3, the reactions in dimethylformarnide (DMF), tert-butanol 
and toluene (entries 2 - 4) resulted in 85 to >99 % conversion. However, the downside of 
these reactions is that they all resulted in lower ee and the conversions were very slow. 
These results clearly indicate that the large excess, such as complete use of the IPA as a 
solvent, is needed for faster conversion and higher ee. 
There seems to be a direct relation between the rate of conversion and the 
enantioselectivity. Although a large excess IPA (112 equiv) is being used in these 
reactions, the conversion of geraniol to citronellol in the mixed solvents media is very 
64 Ikariya, T.; Ishii, Y.; Kawano, H.; Arai, T.; Saburi, M.; Yoshikawa, S.; Akutagawa, S. Chem. Commun. 
1985,922. 
slow. In some cases, for example in 1,2-dimethoxyethane (entry 6, Table 3.3), the 
reaction went to only 2% conversion. 
Table 3.3: Transfer Hydrogenation with RuItolBINAP in Mixed Solvents. 
+ 0 + j;, 
[RuCODCI~], 
(S)-lolBINAP 
KOH 
geraniol sobent, 100 O C  citronello, acetone 
*Reaction performed at 40 OC. 
"GC conversions measured with a HP-5 column (J&W Scientific, 15 m x 0.32 mm). 
# 
ee measured on RT-BetaDEXsa GC column, 30 m x 0.32 mm ID x 0.25 mm. 
b 
ee measured by derivatization with Mosher acid chloride 
The amount of IPA in the reaction may be important in the conversion rate. 
However, since the conversion is different with different solvents, there might be a 
solubility issue or a solvent interaction with the catalyst system. If any of the reagents, 
KOH, (S)-tolBINAP, or [Ru(COD)C12],, have low solubility in the solvent, that will 
result in slower conversion. In addition, if the solvents have greater affinity for the 
catalyst than PA,  that may result in less reactive sites for the reaction to occur, thus 
slower conversion. 
Why would a slower reaction rate affect the enantioselectivity? It is well known 
that transfer hydrogenation with P A  is a reversible process.20a At low IPA 
concentrations, the en01 intermediate (0 in our proposed mechanism (Scheme 3.12) may 
go back to the allylic intermediate (b). Depending on the conformation of the reversibily 
formed allylic intermediate (cis or trans), the (S) or the (R) product may be obtained. This 
point will be further clarified when the proposed mechanism is discussed in Section 3.2.8. 
We've already demonstrated that asymmetric transfer hydrogenation of geraniol (trans) 
and nerol (cis) with (S)-tolBINAP gives opposite configurations of citronellol (Table 3.2, 
entries 1 and 4). Similarly, transfer hydrogenation of the cis and trans isomers of the 
reversibily formed allylic intermediate (b in Scheme 3.12) gives both (S) and (R) 
citronellol, which results in lower ee. Therefore, slow reactions give lower ee's. 
The reaction didn't go in methylene chloride (entry 5, Table 3.3), however, this is 
likely due to the lower temperature used, 40 "C. In 1,2dimethoxyethane (entry 6,  Table 
3.3), the reaction went to only 2% conversion after 117 hours at 100 "C. This is an 
example of a solvent that has strong affinity for the catalyst. The oxygens in the 1,2- 
dimethoxyethane may chelate the ruthenium center to give the inactive catalyst I1 below. 
A similar diamine catalyst to 11, Ru-(S)-XylBINAP-DAIPEN (I), has been reported to be 
very active in the reduction of carbonyl groups under gaseous and transfer hydrogenation 
 condition^.^. I5The nitrogen groups in the diamine catalyst are believe to take part in the 
hydrogenation process (metal-ligand bifunctional mechanism Figure 1.9). This 
79 
mechanism doesn't involve coordination of the substrate to the metal center. The 
hydrogenation is believed to take place via a six-membered ring transition state 
intermediate (Figure 1.9). If I1 is generated with l,Zdimethoxyethane, it may not be able 
to catalyze the isomerization step of the allylic alcohol to the carbonyl prior to transfer 
hydrogenation, which we are proposing as the mechanistic route of our ATH reaction 
(Section 3.2.8). The isomerization step requires coordination of the substrate to the metal 
center. 
Ru-(S)-XylBINAP-DAIPEN 
(1) 
Active 
3.2.2 Asymmetric Transfer Hydrogenation with a Cyclic Alcohol Donor 
Another study we wanted to conduct was the effect of a cyclic hydrogen donor in 
our system. Cyclohexanol was selected because of its high melting point of 20 - 22 "C. 
Its use in our reaction as a hydrogen donor would eliminate the cryogenic conditions 
needed to freeze P A  (m. p. = -89.5 "C) during the degassing process. The required 
freeze-pump-thaw could easily be done in an ice-water bath instead of the liquid nitrogen 
bath used for PA.  
Table 3.4: Transfer Hydrogenation with Ru/(S)-tolBWAP in Cyclohexanol, 
[RuCODCI~], 
(S)-tolBINAP 
KOH 
geraniol citronellol cyciohexanone 
'~euterated cyclohexanol. 
%C conversions measured with a HP-5 column (J&W Scientific, 15 m x 0.32 mm). 
bee measured on RT-BetaDEXsa GC column, 30 m x 0.32 mm ID x 0.25 mm. 
Using our best conditions (substrate/[Ru(COD)Cl~],,/KOW(S)-tolBINAP molar 
ratio = 10/1/2/2), we conducted the reactions in 0.01 M geraniol in cyclohexanol. The 
results are summarized in Table 3.4. To have a direct comparison with P A ,  the first 
reaction was set at 100 "C for two hours (entry 2). This reaction went to only 4% 
conversion and the ee wasn't determined. 
To increase the conversion, we decided to increase the temperature of the 
reaction. At 160 "C (entry 4), the reaction went to 92% conversion in 4 hours and the ee 
was 66%. At a higher concentration, 0.02 M (entry 5), the reaction went to 100% 
conversion in 4 hours, but the ee dropped to 26%. This is a very clear example that 
higher concentration results in lower ee. However, this trend doesn't seem to continue 
beyond 0.02 M concentration. At 0.1 M concentration, the ee remained at 24% (entry 6). 
Entry 7 shows the reaction with dxz-cyclohexanol at 0.1 M concentration which was 
conducted in an 8 hour reaction time. This reaction results in lower ee (1 1%) than the 
non-deuterated reaction at the same concentration (entry 6). This might be the result of 
the difference of reaction time or subtle differences in cyclohexanol versus du- 
cyclohexanol. 
3.2.3 The Effects of Chiral Alcohol in Asymrnehic Transfer Hydrogenation 
The use of chiral solvents in asymmetric synthesis is well known.65 For example 
Vo-Thanh reported a Baylis-Hillman reaction of benzaldehyde and methyl acrylate in the 
presence of a chiral ionic liquid to give the alkoxyester in 44% ee (Scheme 3.2)." The 
chirality of the product came from the ionic liquid solvent, which was the only source of 
chirality in the reaction. Likewise, we wanted to investigate the effect of a chiral solvent 
in the enantioselectivity of our ATH reaction. 
65 a) Baudequin, C.; Baudoux, I.; Levillain, I.; Cahard, D.; Gaumont, A.C.; Plaquevent, I. C. Tetrahedron: 
Asym. 2003,14,3081; b) Handy, S. T .  Chem Eur. 5.2003,9,2938; c) Ding, J.; Armstrong, D. W. 
Chirality 2005,17,28 1 .  
66 Baudequin, C.; Bregeon, D.; Levillain, I.; Guillen, F.; Plaqueventb, I. C.; Gaurnonta, A. C. Tetrahedron: 
Asym. 2005,16,3921. 
Scheme 3.2: Baylis-Hillman Reaction with Chiral Solvent. 
+ &OMe 
DABCO, 30 OC Arv 
Ar * OMe Rhh'c8~l , 30 - 78 %yield, 
Ph 20-44%ee 
T fo- 
To conduct this study, we selected 2-pentanol, which was used as solvent as well 
as hydrogen donor in the reaction. The solvent 2-pentanol was selected to conduct this 
study because of the following reasons: first, the (S) and (R) enantiomers are 
commercially available; second, it is the closest secondary alcohol to P A  that has a 
higher melting point (-50 "C) than P A  (-89.5 "C), 2-butanol has a melting point of -115 
'C. The use of 2-pentanol allowed the freeze-pump-thaw process in dry icelacetone bath 
(-78 "C) instead of the liquid nitrogen bath used for P A .  
Using 2-pentanol, we ran the reactions at 0.01 M concentration of geraniol and a 
substrate/[Ru(COD)Cl~]~lKOH/(S)-tolBINAP molar ratio of 10/1/212. The results are 
summarized in Table 3.5. The reaction in racemic 2-pentanol went to 84% conversion 
and 79% ee at 100 "C in 2 hours (entry 1, Table 3.5). At 120 "C, the reaction with 
racernic 2-pentanol went to 98 - 100 % conversion and 77% ee in 4 hours (entry 2, Table 
3.5). This ee result was promising as it suggested that there could be improvement if a 
pure chiral2-pentanol was used. 
Table 3.5: Asymmetric Transfer Hydrogenation with Chiral Solvents. 
geraniol KOH citronellol 2-pentanone 
Entry 1 Solvent ( Temp. ("C) ( Time (h) 1 %  con^.^ I eeb (R) 
bee analysis measured with a GC Column R T - ~ e t a ~ ~ ~ s a  30 m x 0.32 mm ID x 0.25 
mm. 
3 
4 
5 
6 
The reaction with (S)-2-pentanol gave 86 - 100 %conversion and 69 - 72 % ee in 
2 - 4 hours at 120 "C (entries 3 and 4, Table 3.5). The reaction with (R)-2-pentanol was 
'GC conversions measured with a HP-5 column (J&W Scientific. 15 m x 0.32 mm). 
(S)-2-pentanol 
(S)-2-pentanol 
(R)-2-pentanol 
(R)-2-pentanol 
slower and resulted in only 50% conversion and 2% ee after 2 hours (entry 5, Table 3.5) 
compared to the 86% conversion obtained with (S)-2-pentanol. This reaction went to 
120 
120 
120 
120 
100% conversion and 26% ee in 4 hours under the same conditions (entry 6, Table 3.5). 
These results indicate a striking difference in the selectivity of (S)-2-pentanol versus (R)- 
2 
4 
2 
4 
2-pentanol with the Ru/(S)-tolBINAP catalyst system as (S)-2-pentanol is a better match. 
Although we were hoping that the ee would increase with a properly matched chiral 
84 
86 
100 
50 
100 
72 
69 
2 
26 
solvent, we found that racemic 2-pentanol is as efficient as the (S)-2-pentanol, therefore 
there is no advantage of using a c h i d  solvent as the hydrogen donor. 
It is also worth noting that the reactions with the (S) and (R)-2-pentanol were 
conducted in a much lower scale (118) of the one with racemic 2-pentanol. It was difficult 
to measure some of the reagents at that scale. This might be the reason why the ee from 
the (S)-2-pentanol is slightly lower rather than being equal to what was obtained from 
racemic 2-pentanol. 
3.2.4Asymmehic Transfer Hydrogenation with Pre-Made Catalyst, [(S-)BZNAP)l 
Ru(ZZ)Cl~ 
Since the catalyst cocktail method of combining [RuCODC12], with (S)-tolBinap 
leads to an imprecisely defined catalyst precursor, we were interested in performing the 
asymmetric transfer hydrogenation with a pre-made catalyst with known structure. Our 
Ru/(S)-tolBINAP catalyst is prepared in situ from commercially available ruthenium 
cyclooctadiene dichloride polymer, [RuCODClz],, and (S)-tolBINAP, which presumably 
forms [(S)-tolBINAP]Ru(K)CIZ, complex A shown in Scheme 3.3. In the presence of (R)- 
BINAP, the catalyst species would then be [(R)-BINAP]Ru(II)Clz, complex B in Scheme 
3.3. These structures were supported by Ikariya who demonstrated that a dimer of 
complex B, RuzCL[(-)-BINAP]z(N&), can be obtained with similar starting materials in 
the presence of triethylamine in refluxed toluene.64 According to Ikariya, the dimer 
should provide a co-ordinatively unsaturated ruthenium species, RuC12L2 (L = phosphine 
ligand), which is similar to our proposed complexes A and B. Also, the dimer, Ru2C14[(-)- 
BINAP]2(NEt& is known to exhibit excellent catalytic acitivity and high stereoselectivity 
for the hydrogenation of a,a-unsaturated amino acids (Scheme 3.4).64 
To investigate that the structures of our in situ prepared catalysts are complexes A 
and B (Scheme 3.3), we tried our ATH reaction with a commercially available catalyst, 
[(S)-BINAP]Ru(II)C12, complex C in Scheme 3.3. This catalyst has the same 
configuration as our in situ prepared catalyst A, but they are slightly different chemically 
because of the difference between a tolyl-substituted ancillary group and a phenyl group. 
To have a more exacting comparison, the results obtained with the commercial catalyst C 
will be compared to the reaction with [RuCODC12]d(R)-BINAP, entry 6 in Table 3.1. 
Scheme 3.3: Chemical Structures of [(S)-tolBINAP]Ru(II)C12 (Complex A), 
[(R)-BINAP[Ru(II)C12 (Complex B) and [(S)-BINAP]Ru(II)C12 (Complex C). 
(S)-tolBlNAPRu(ll)CI2 
complex (A) 
(R)-BINAPRu(II)CI~ 
complex (0) 
Commercially Available 
(S)-tolBINAPRu(ll)C12 
complex (C) 
Scheme 3.4: Hydrogenation of a$-Unsaturated Amino Acids with Ru2C14[(-). 
BINAP]~(NE~L~) .~~  
Table 3.6: ATH with Pre-made Catalyst [(S)-BINAPIRu(QC12 (Complex C in Figure 
3.3) Comppzd with in situ Prepared Catalyst B. 
Cafa yt or C 
IPA KOH 1 C C  OC 
geran o c trone o acetone 
concentrat~on 
%C conversions measured with a HP-5 column (J&W Scientific, 15 m x 0.32 mm). 
bee analysis measured with a GC Column RT-BetaDEXsa 30 m x 0.32 mm ID x 0.25 
mm. 'ee analysis measured on the (R)-Mosher ester on a Chiralcel OJ-H column (Daicel, 
250 mm x 4.6 mm). *GC conversions measured with a DB-5 column (J&W Scientific, 15 
m x 0.32 mm). 
It has already been demonstrated that tolBINAP gives slightly better 
enantioselectivity than BINAP (Table 3.1). Here we want to compare the results from two 
sterically similar RulBINAP catalysts: the pre-made catalyst [(S)-BINAP[Ru(II)C12 (C) 
and our in situ prepared catalyst [(R)-BINAPIRu(QC12 (B). As shown in Table 3.6, 
commercially available catalyst (S)-BINAPRu(Il)Clz (C) was able to fully convert 
geraniol to (R)-citronellol in 90% ee (entry 2). This result is slightly higher than that 
obtained from our in situ prepared catalyst B (87% ee) with, of course, the opposite 
configuration. The commercial catalyst (C) was also able to convert nerol to (S)- 
citronellol in 91% ee (entry 3). The only difference is that this catalyst offers the 
advantage of maintaining the enantioselectivity at higher concentration. At 0.02 M and 
0.1 M geraniol, catalyst C gives (R)-citronellol in 92.8% and 93.4% ee, respectively, with 
a slightly increase in ee compare to the reaction at 0.01 M concentration. This is likely 
due to a higher concentration of the "active" catalyst species that is obtained from the 
pure precatalyst compared to what is obtained from the catalyst cocktail. 
To further test the efficiency of the commercial catalyst, we decided to run a set of 
experiments without the three freeze-pump-thaws. In this series, the IPA was degassed 
with argon for 1 hour and the reagents were charged under argon. Under these conditions, 
the pre-made catalyst, [(S)-BINAP[Ru(II)Clz, was able to give citronellol in 95% 
conversion and 91.7% ee in two hours (Table 3.7). This kind of conversion was never 
obtained under similar conditions with our in situ prepared catalysts. This suggests that 
the cryogenic freeze-pump-thaw procedure is necessary for the preparation of the catalyst, 
but not for the transfer hydrogenation reaction. 
Table 3.7: ATH with Pre-made Catalyst [(S)-BINAP]Ru(II)C12. 
[(S)-BINAP]RU(II)CI~ 
IPA, KOH,100 OC 
- 
geraniol (R)-citronellol 
In Table 3.7, we explore the effect of reaction time on reaction conversion and ee. 
Entry 
1 
- 
2 
3 
4 
Each data point in Table 3.7 represents a separate reaction. Like with the in situ prepared 
catalyst, attempts to sample the reaction mixture result in deactivation of the catalyst. 
aGC conversions measured with a HP-5 column (J&W Scientific, 15 m x 0.32 mm). 
b ee analysis measured with a GC Column RTBetaDEXsa 30 m x 0.32 mm ID x 0.25 
mm. 
Time (min.) 
30 
60 
90 
120 
That is additional evidence suggesting the structural similarity between the commercial 
and the pre-made catalysts. 
%  con^.^ 
80.3 
80.5 
88.5 
95 
3.2.5 Asymmetric Transfer Hydrogenation of pGeraniol 
% eeb 
93 
91.6 
92.2 
91.7 
- 
In gaseous hydrogenation, there is a reciprocal relationship between nerol and 
geraniol. These two substrates give opposite configuration of citronellol after 
hydrogenation with either (S) or (R) RuIBINAP catalyst (Scheme 3.5).3 A similar 
observation was made in our transfer hydrogenation system (Table 3.1, entry 5 and 6 and 
Table 3.2, entry 1 and 3). In contrast, in the presence of the (S)-RuIBINAP, y-geraniol 
gives (S)-citronellol in 85 - 93 % ee (Scheme 3 . ~ ) . ~ '  We wanted to investigate if this 
relation also exists in our transfer hydrogenation system. 
Since y-geraniol is not commercially available, we prepared it following the 
conditions shown in Scheme 3.6.68 The reaction is a one-pot synthesis, which involves 
the in sifu preparation of disiamylborane (31) stating with commercially available 
isoprene (30). Treatment of 31 with myrcene gives the the trialkylborane (32), which 
subsequently hydrolyses to the crude product. Purification of the crude by fractional 
distillation gives y-geraniol(33) in 15% yield and 97% purity (GC area percentage). 
Scheme 3.5: Reciprocal Relationship Between Nerol and Geraniol. 
geraniol 
J+--J-OH 
gamma-geraniol 
+ H2 OH 
and ATH (S)-citronellol 
96 - 99 % ee 
61 Sun, Y.; LeBlond, C.; Wang, 1.; Blackmond, D. G.; Laquidara, J.; Sowa, Jr., J. R. J. Am Chem Soc, 
1995, 11 7(5O), 12647. 
68 Brown, H. C.; Singh, K. P.; Gamer, B.  J. J. Organomet. Chem. 1963,1,2.  
Scheme 3.6: Preparation of y-Geraniol. 
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Attempts to perfom transfer hydrogenation of y-geraniol under our best 
conditions with substrateI[Ru(COD)Cl&,KOH/(S)-tolBINAP molar ratio = 10/1/2/2, 
result in 40.7% conversion to citronellol after 2 hour at 100 "C. Prolonged heating of the 
reaction mixture for up to 6 hours results in 50.6% conversion to citronellol (Table 3.8). 
As usual, each data point represents a separate reaction; attempts to withdraw samples 
from the ongoing reactions result in deactivation of the catalyst. 
An interesting observation we made in the transfer hydrogenation of y-geraniol 
with two equiv of base (that is, with respect to the catalyst load) is the formation of small 
amounts of nerol and geraniol in every reaction. With two equiv of base, the amount of 
geraniol formed in every reaction exceeds the amount of nerol formed; as a result the (R)- 
citronellol is obtained in a small excess (19 - 34 % ee). Thus, y-geraniol gives low ee 
under ATH conditions and the chiral direction is different from that of the hydrogenation 
reaction, 85 - 93 % ee (S). In fact, the chiral direction seems to correlate with the slight 
excess of geraniol detected in the reaction. 
Table 3.8: Asymmetric Transfer Hydrogenation of y-Geraniol with Two Equivalents of 
Base. 
+Y-geraniol 
+% nerol 
t % g e r a n i o l  
*% citronellol 
. 
7 * 
0 30 120 240 360 
Time (min.) 
Time ygeraniola nerola geraniola citronellola % eeb I (mi@ I (GC a m  8) I (GC area ~ a )  (GC area %) I (GC a m  %) 1 ( R ) I 
bee analysis measured with a GC Column RT-BetaDEXsa 30 m x 0.32 mm ID x 0.25 
mrn. 
360 
In an attempt to increase the conversion of y-geraniol, the amount of base was 
increased to four equiv. with a substratd[Ru(COD)CI&IKOW(S)-tolBINAP molar ratio 
of 10/114/2. In two hours, the reaction went to 87.93% conversion; more than double of 
the percent conversion obtained with two equiv of base over the same period of time. On 
"GC conversions measured with a HP-5 column (J&W Scientific, 15 m x 0.32 mm). 
49.4 
the other hand, the amount of (R)-citronellol produced in every reaction decreases in a 
manner that directly corresponds to the lower amount of geraniol and increasing amount 
92 
2.33 
~ - 
8.13 36.17 32.84 
of nerol produced in the reactions with four equiv of base. This set of experiments results 
in very low ee, which shifts from 9.72% (S) to 8.2% (R) citronellol (Table 3.9). 
Table 3.9: Asymmetric Transfer Hydrogenation of y-Geraniol with Four Equiv of Base. 
t Y-geraniol 
4- % nerol 
0 15 30 60 120 240 360 
Time (min.) 
0 
15 
30 
120 
b ee analysis measured with a GC Column RT-BetaDEXsa 30 m x 0.32 mm ID x 0.25 
mm. 
96.71 
45.03 
24.7 
240 
- 
360 
Our results indicate that ATH of the homo-allylic alcohol y-geraniol is possible, 
however, the reaction is relatively slower compare to the ATH of nerol and geraniol and 
93 
I I I I I 
12.07 
0 
1.13 
1.46 
a GC conversions measured with a HP-5 column (J&W Scientific, 15 m x 0.32 mm). 
21.71 
12.82 
0.57 
0 
1.21 
1.04 
1.39 
1.41 
0.24 
0 
44.53 
59.42 
0.76 
0.88 
N/A 
4.18 (S) 
9.72 (S) 
64.17 7.44 (S) 
60.69 
64.18 
1.72 (R) 
8.2 (R) 
the enantioselectivity obtained is very low and sensitive to the concentration of base. This 
leads us to believe that the mechanism of our ATH system is different from the gaseous 
hydrogenation. In addition, all the reactions with y-geraniol generate small amounts of 
nerol and geraniol. Therefore, we think that the ATH of y-geraniol may take place via 
isomenzing to nerol and geraniol prior to ATH. Knowing that the ATH of nerol and 
geraniol give opposite configuration of citronellol (S) and (R), respectively, isomerization 
of y-geraniol to both nerol and geraniol prior to ATH would result in what we observe in 
our experiments; low enantioselectivity. 
3.2.6 Zsomerization of Geraniol 
Transition metal catalyzed isomerization of allylic alcohols to carbonyl 
compounds is well known.69 Many examples of primary, secondary and cyclic alcohols 
have been reported to oxidize under intramolecular redox processes. The earliest 
examples of allylic alcohol isomerization were reported by Botteghi and Giacomelli in 
1976.~~'  These examples had limited success in terms of conversion and 
enantioselectivity. For example, HRh(CO)(PPh3)3/DIOP catalyses the isomerization of 2- 
methylbut-2-en-1-01 to the corresponding aldehyde in 98% conversion and 4% ee. A 
similar reaction resulted in 0% conversion when there was a phenyl group attached on the 
allylic bond (Table 3.10). 
69 
a) Ito, M.; Kitahara, S.; Ikariya , T. J.  Am. Chem. Soc. 2005,127 (17), 6172; b) Drift, R. C. van der; 
Bouwman, E.; Drent, E. J. Organomet. Chem. 2002,650, 1 ;  c) Uma, R.; Crvisy, C.; Gre, R. Chem. Rev. 
2003,103 (I), 27; d) Slugovc, C.; Rba, E.; Schmid, R.; Kirchner, K.  J.  Organomet. Chem. 1999,18 (20), 
4230. 
Table 3.10: Asymmetric Isornerization of Allylic Alcohols with HRh(CO)(PPh&/JXOP 
Catalyst 
Scheme 3.7: Asymmetric Isornerization of Geraniol with Rh-BINAP. 70.71 
geraniol S-citronellal 
70% yield, 37% ee 
diethylgeranylamine R-citronellal enamine 
100% yield, 96-99% ee 
Another example includes cationic-Rh-BINAP catalyzed isomerization of geraniol 
to citronella1 in 70% yield and 37% ee (Scheme 3.7).70 This yield is considerably lower 
'O Tani, K. Pure &Appl. Chem. 1985,57, 1845. 
95 
compared to the excellent yield obtained with the corresponding allylic amines; the major 
step in the industrial synthesis of menthol and other terpenes, which proceeds in 100% 
yield and 95 - 99 % ee. 71 
The mechanism of the isomerization of geraniol to citronellal is believed to 
proceed via the same route as the isomerization of geranylamine, where the nitrogen atom 
plays an important role.7' There is no experimental evidence on how the hydrogen 
transfer takes place, but two types of mechanisms have been proposed (Figure 3.3).69c 
The type I mechanism takes place via an alkylmetal intermediate. In this case, the 
catalyst is a metal-hydride [M-HI, which is either isolated or generated in situ. The type 
II mechanism takes place via a x-ally1 intermediate. In this case, the transition metal [MI 
leads the migration of the hydrogen from position 1 to position 3 of the allylic alcohol via 
a x-ally1 metal hydride intermediate. 
In our system and the presence of a hydrogen donor, geraniol is converted to 
citronellol; the aldehyde citronellal has never been detected in the reactions using the 
ATH conditions of catalyst, hydrogen donor and base. To see if isomerization was taking 
place in our ATH reactions, we decided to run a reaction in the absence of the hydrogen 
donor, P A .  The isomerization reaction was conducted in t-butanol, a non-oxidizable 
alcohol. Using a substratel[Ru(COD)C12]JKOW(S)-tolBINAP molar ratio of 10/1/2/2, 
geraniol (1) was converted to citronella1 (34) in 21% yield (Scheme 3.8). This reaction 
also gave citronellol(2) in 13% yield and 77% ee. This result is reminiscent, vide supra, 
to the origin of this project where geraniol acts as a hydrogen donor to give citronellol in 
71 Otsuka, S. ;  Tani, K. Synthesis 1991, 665 
27% yield and 50% ee (Scheme 3.1). In this reaction, we were able to identify all the 
major components of the isornerization reaction: the isomerized product citronella1 (34), 
the reduced product citronellol (2) and the oxidized product citral (35), which was 
obtained in equal amount as citronellol, 13% yield. 
Figure 3.3: Proposed Mechanism for Asymmetric Isomerization of Allylic 
Alcohols. 
M-H Mechanism  1' = p H  M-H 
Scheme 3.8: Asymmetric Isomerization of Geraniol. 
A KOH, BuOH 
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In an attempt to prevent the transfer hydrogenation from occurring, we repeated 
the isomerization reaction without base, but, this resulted in 0% conversion (Scheme 3.8). 
Isomerization of geraniol to citronellal is possible with our Ru-BNAP catalyst system. 
However, the isomerized product was never detected in our reaction system. If citronellal 
is an intermediate, it may be rapidly hydrogenated in the presence of the hydrogen donor, 
P A .  
3.2.7 Deuterium Experiments 
To investigate which pathway our asymmetric transfer hydrogenation follows, we 
conducted a series of deuteration experiments. These will provide two key answers: first, 
the transfer of deuterium to the substrate will confirm that the alcohol is the hydrogen 
source in the reaction, second, the position of the deuterium on the reduced product will 
tell which path the reaction follows. Some of the possible outcomes of the deuterium 
experiment are highlighted in Scheme 3.9. 
Scheme 3.9: Potential Products from the ATH with Deuterated P A .  
Via direct allylic 
Product A 
Via isomerization with a metal deuteride (M-DJ, metal ligand intermediate 
D j o D  
M-D 
* R - R R D 
a I Product B 
Via isomerization with a metal (M), *ally1 isomerization 
Product C 
I Product D 
Product E 
For simplicity, we are leaving the possibility of deuterium exchange until later. If 
the reaction goes via direct hydrogenation of the C=C, the deuteriums will transfer 
directly across the double bond of the allylic alcohol and product A will be formed 
(Scheme 3.9). If the allylic bond isomerizes to the enol, via the Type I M-H mechanism 
proposed in Figure 3.3, prior to transfer hydrogenation, product B will be formed. Under 
the same isomerization pathway, if the en01 tautomerizes to the aldehyde prior to transfer 
hydrogenation, product C will be formed. However, if the isomerization takes place via 
the Type I1 x-ally1 mechanism in Figure 3.3, transfer hydrogenation of the en01 and the 
aldehyde will give products D and E, respectively. 
Using our optimum conditions, substratel[R~(COD)C1~]JK0W(S)-tolBINAP 
molar ratio = 10/1/2/2, the asymmetric transfer hydrogenation of geraniol was conducted 
in ds-isopropanol to give d3-citronellol (36) in 86% yield and 98% ee (Scheme 3.10). This 
product was characterized by GUMS and various NMR experiments. 
Scheme 3.10: Asymmetric Transfer Hydrogenation of Geraniol with Deuterated IPA. 
[RWOD)C1dn S)-tolBlNAP + Hp 
KOH 
dB-IPA 
100 "C, 4 h 
1 36 
geraniol d3-citronellol 
86% yield, 97.8% ee (R) 
This experiment answers our first question regarding whether transfer 
hydrogenation took place. The GCIMS of the product shows a mass of 159, which 
indicates the formation of d3-citronellol (Figure 3.4). The presence of deuterium on the 
product indicates that deuterium did transfer from ds-PA to geraniol, giving d3- 
citronellol. 
The second question on how the transfer hydrogenation occurs will be answered 
in the following discussion. The proton NMR of the product (Figure 3.5) shows a signal 
at 3.64 - 3.67 ppm that integrates as 0.98. This indicates the absence of one proton or the 
presence of one deuterium on C1. In regular citronellol, that signal integrates for two 
protons. In addition, the signals of the C3' protons at 0.89 - 0.92 ppm, which integrates as 
3.2, and occurs as show a doublet. The multiplicity of the C3' protons indicates the 
presence of one proton (no deuterium) on C3, which eliminates the possibility of direct 
addition of hydrogen to the C=C. 
F i r e  3.4: Segment of GCIMS of d3-citronellol. 
Figure 3.5: The 'H NMR of d+itronellol. 
- 
1 
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The I3c NMR shows a tremendous supression of C1 and C2 (Figure 3.6). This 
indicates the presence of deuterium at these two locations. Furthermore, deuterium 
couples with carbon, as a result the deuteriumcarbon peaks will split. Sure enough, a 
closer look at C1 (Figure 3.7) reveals a triple with a J ~ D  = 21 which matches the literature 
reference for the CD coupling constant ( J ~ D  = 20-30 Thus, this confirms the 
presence of one deuterium on C1. A closer look at C2 (Figure 3.7) shows a multiplet. 
Since the deuteriums on C2 are diastereotopic (alpha to the chiral center), it is reasonable 
to suggest that the multiplet is an overlap of two triplets; a typical pattern for CDD'. The 
13 C NMR clearly indicates the location of the three deuteriums on our d3citronellol. 
72 Pavia, D. L.; Lampman, G. M.; Kriz, G .  S.; Vyvyan, J .  R.  Introduction To Spectroscopy, 4" Ed., Brooks/ 
Cole, Cengage Learning, 2009. 
Figure 3.6: I3c NMR of d3-citronellol. 
Figure 3.7: Enlarged I3c NMR of dTcitronellol. 
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To confirm the absence of protons on C2, we decided to run an HMQC NMR of 
our d3citronellol and compare this spectrum to that of regular citronellol. HMQC 
(Heteronuclear Multiple-Quantum Coherence) is a two-dimensional inverse proton- 
carbon correlation technique.73 This NMR experiment is selective for direct C-H bonds. 
Therefore, every carbon that is directly attached to a hydrogen (but not a deuterium) will 
show a correlation. In the enlarged HMQC spectrum of citronellol (Figure 3.9), we see 
the correlations for the two diastereotopic protons on C2. These two correlations are 
reduced to a trace signals in our d3-citronellol product (Figure 3.8). 
Figure 3.8: Enlarged HMQC NMR of d3-citronellol. 
A more direct analysis of the d3-citronellol is the 'H NMR shown in Figure 3.10. 
Integration of the 3.64 ppm deuterium of C1 for I deuterium results in simultaneous 
integration of the 1.34 and 1.56 ppm deuteriums of C2 as 1.61 deuteriums which is close 
to the expected value of 2 deuteriums. This result confirms that the major product formed 
73 Silverstein, R. M.; Webster, F. X. Spectrometric Identification Of Organic Compounds, 6th Ed., John 
Wiley & Sons: New Yolk, 1998. 
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from our ds-PA experiment is indeed compound 36 in Scheme 3.8. The two small 
signals at 0.86 and 1.1 ppm do not seem to be related to the product. 
Figure 3.9: Enlarged HMQC NMR of Regular Citronellol. 
HQCGP C W 1 3  D:\\ N% 59  
Figure 3.10: 'H NMR of d3-citronellol. 
The position of the deuterium on the product helped us determine which pathway 
the hydrogenation followed. Going back to Scheme 3.9, we can eliminate the first three 
possibilities, since our product (36) doesn't have any deuterium on C3. Therefore, we can 
say that neither direct hydrogenation of the C=C bond, nor a Type I metal hydride (M-H) 
isomerization followed by transfer hydrogenation is the mechanistic route of our system. 
The isomerization in our system must have been taken place via the Type I1 x-ally1 
mechanism (Scheme 3.11). The en01 then leaves the catalytic cycle and undergoes 
tautomerization in the presence of the deuterated solvent to generate the aldehyde, which 
reenters the catalytic cycle for transfer hydrogenation. 
Scheme 3.11: Isomerization/ATH of Allylic Alcohols Via rc-Allyl Mechanism with 
d8-PA. 
+ 
ismerizaticm via " M t " 1  
a-allyl mechanism 
k , M - H 9 '  
Scheme 3.12 summarizes the mechanism of the ATH reaction. Starting with the 
allylic alcohol a, a base generates the alkoxide b, which coordinates to a selective side of 
the ruthenium complex to produce c. A  x-ally1 intermediate d is generated, which 
subsequently undergoes a metal-mediated 1,3-hydrogen shift (the chiral induction step) to 
give the chiral intermediate e. p-elimination releases the chiral en01 f. This concludes the 
isomerization part of the process. In the presence of a deuterated alcohol (DOR), the en01 
f undergoes deuterium exchange follow by tautomerization, which enables incorporation 
of deuterium on C2 to give the aldehyde g. Transfer hydrogenation of g follow by an 
aqueous workup gives the d3-citronellol product h. This experiment clearly indicates the 
isomerization as the chiral induction step. Remarkably the direction of chirality is the 
same as the gaseous hydrogenation even though the mechanism is different from what 
occurs in gaseous hydrogenation.3 
Scheme 3.12: Proposed Mechanism for Asymmetric Transfer Hydrogenation. 
It is unclear if all these steps are reversible. However, it is well known that 
transfer hydrogenation with P A  is a reversible process.208 In addition, our experiments in 
low P A  concentration, which are slow in conversion rate, result in lower ee. This leads 
us to believe that under low P A  concentration or low hydrogen dogor concentration, the 
aldehyde g, which is in equilibrium with f, goes back to the alkoxide b. During the 
reverse process, the alkoxide may switch from the original trans to cis configuration. This 
might be the source of the low enantioselectivities obtained in the reactions with low P A  
concentrations (Table 3.3) or the slow reactions with cyclohexanol and 2-pentanol 
(Tables 3.4 and 3.5). 
We do have evidence that our ATH reaction mechanism involves isomerization of 
the allylic bond to aldehyde prior to hydrogenation. Both steps, the isomerization of 
allylic alcohols to aldehydes 69. 70 and the transfer hydrogenation of carbonyls to 
alcohols, 28, 31, 32 have been reported. However, none of these reports has mentioned the 
reduction of an allylic alcohol. In addition, the isomerized product was never detected in 
our reaction mixtures. Yes, we do have isomerization prior to ATH, but we could not 
make this distinction if we did not perform the mechanistic study. Our observation is that 
allylic alcohols undergo asymmetric transfer hydrogenation in the presence of RulBINAP 
and P A  as hydrogen donor. 
3.3 Conclusions 
In conclusion, asymmetric transfer hydrogenation of allylic alcohols is possible 
and the product can be obtained in high yield and excellent enantioselectivity. The yield 
and the chiral direction of the product is the exact same as the gaseous hydrogenation 
reaction. For example, [RuCODC12],,/(S)-tolBINAP catalyzes the asymmetric transfer 
hydrogenation of geraniol to (R)-citronellol in 90 - 95 % yield and 95 - 98 % ee. This 
yield and enantioselectivity rival gaseous asymmetric hydrogenations of allylic alcohols. 
However, a significant advantage of this ATH reaction is that it eliminates the high 
hydrogen pressures (>30 atmP used for the same transformation. 
This asymmetric transfer hydrogenation reaction is not limited to isopropanol as 
hydrogen donor. Other alcohols, such as racemic and chiral 2-pentanol and cyclohexanol, 
can also be used. In our study with the 2-pentanol, we have demonstrated that a chiral 
solvent is not required to enhance the enantioselectivity. The racemic alcohol can provide 
the same enantioselctivity as the most active chiral alcohol. In our study with 
cyclohexanol, we have demonstrated that the freeze-pump-thaws can be done under non- 
cryogenic conditions. The freeze-pump-thaws can be done at the melting point of the 
solvent used. 
Most of our experiments are done with the [RuCODC12],,/(S)-tolBINAP catalyst 
system as it gave the best yield and the best ee during our screening process. However, 
other ligands including BINAP, (S,S)-MeDUPHOS and (S,S)-iPrDUPHOS can also be 
used. In addition, we have demonstrated that a pre-made catalyst, [(S)-BINAP]Ru(iI)CI2, 
can work efficiently in our system. This catalyst gives the same yield and chiral 
configuration as our in situ prepared catalyst; which suggests that the structure of our 
active catalyst may also be a [BINAP]Ru(II)Cl2 complex. Other experiments with this 
catalyst without the freeze-pump-thaws resulted in no major changes in yield, ee and it 
was possible to increase in substrate to catalyst ratio without affecting ee. Therefore, the 
freeze-pump-thaw process is required only for the in situ preparation of the catalyst. 
Our deuterium experiment indicates that the mechanism occurs through an 
isomerization process, which is very different form the gaseous hydrogenation 
mechanism. Considering that the yield, the chirality and the ee of our product is the exact 
same as the gaseous hydrogenation, and given the fact that transfer hydrogenation is a 
safer procedure, this reaction is a potential route for asymmetric reduction of allylic 
alcohols. 
EXPERIMENTAL SECTION 
I. Chiral Method Development 
A) Derivatizafrafron with Mosher Acid Chloride 
Reagents 
All chemicals were purchased from Aldrich. The R-(+)-methoxy- 
trifluoromethylphenylacetyl chloride had an optical purity of 98% and a GC assay of 
98%. The 4-(dimethy1amino)pyridine (DMAP) and the triethylamine (TEA) were reagent 
grades with chromatographic purities greater than 99%. 
Chromatographic Conditions 
The reaction was monitored by gas chromatography, Hewlett-Packard 5890 Series 
I1 equipped with a flame ionization detector. The column used was a DB-5, J&W 
Scientific, 15 m x 0.32 mm. The chromatographic conditions were: split mode inlet 
(250:l). 250 "C; column temperature 60 - 175 "C at 3 'Umin, He flow 30 mumin, 15 
psi; detector 250 OC; 10 pl injection. The diastereomeric purity was determined on a 
Hewlett-Packard 1050 Series high performance liquid chromatography (HPLC). The 
column used was a Diacel Chiralcel OJ-H, 250 mrn x 4.6 mm. The mobile phase was a 
mixture of HPLC grade hexanes and ethyl alcohol (EtOH), 90:lO to 5050 EtOH:hexanes, 
0.6 mumin, 20 minute gradient; room temperature; 210 and 220 nm. The diastereomeric 
excess was calculated based of HPLC area percent of the R-Mosher-R-citronellyl ester 
and R-Mosher-S-citronellyl ester. 
Reaction Conditions 
To an ice cold solution of citronellol (35 mg, 0.22 mmol) in 3.5 rnL 
dichloromethane (DCM) at 0 OC, was added (R)-Mosher acid chloride (123.5 p1, 0.66 
mmol), triethylamine (92 PI, 0.66 rnmol), and 4dimethylaminopyridine (2.7 mg, 0.022 
mmol). The mixture was refluxed for 4 hours or until GC revealed less than 1% 
citronellol. After cooling to room temperature (rt), hexanes (5 mL) was added and the 
reaction mixture was washed with saturated sodium bicarbonate (NaHC03), water, 0.1 
normal aqueous hydrochloric acid (HCI), and water, respectively. The organic was dried 
over magnesium sulfate (MgS04), filtered, and then concentrated to a crude oil. Without 
further purification, the crude oil was diluted in 1:l HPLC grade Et0H:hexanes and 
analyzed by HPLC for diastereometic purity. 
B) Derivatrkation with S-Naproxen 
Reagents 
The (S)-Naproxen was isolated from commercially available drug ~ l eve@.  All 
other reagents, the oxalyl chloride, the triethylamine (TEA) and the 4- 
(dimethy1amino)pyridine (DMAP) were purchased from Aldrich with purities greater than 
99%. 
Analytical Conditions 
The first step of the reaction (Scheme 2.3) was monitored by TLC using 85:15/ 
hexanes:acetone. The melting point of the acid chloride product (28) was compared to the 
literature value (91 - 94 "C). The second step was monitored by GC for the disappearance 
of citronellol (23) on a Hewlett-Packard 5890 Series II equipped with a flame ionization 
detector. A DB-5, J&W Scientific, 15 m x 0.32 mm column was used. The 
chromatographic conditions were: split mode inlet (250:1), 250 "C; column temperature 
60 - 175 "C at 3 "Clmin, He flow 30 mumin, 15 psi; detector 250 "C; 10 p1 injection. 
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During the chromatographic purification, TLC was used to analyze the purity of the 
fractions. Satisfactory separation was obtained using 7:3/ hexanesacetone plus I drop 
phosphoric acid (&Pod) in the TLC analysis. The final product S-Naproxen-ester 29 was 
characterized using a 500 MHz Varian NMR equipped with Inova software in deuterated 
chloroform (CDC13). The relaxation time was 1 second for both proton and carbon 
experiments, with 8 and 256 scans, respectively. 
Reaction Conditions 
Step I :  Preparation of (S)-Naproxen Acid Chloride 
Ten equiv of oxalyl chloride (1.41 mL, 13 mmol) was added to solid (S)- 
Naproxen (300 mg, 1.3 mmol). The mixture was stirred at room temperature (rt) for 30 
min and formed a solution. The excess oxalyl chloride was removed under reduced 
pressure at rt. Four volumes of dichloromethane (1.2 rnL) were added, and then hexanes 
(30 mL) was added in small portions. The mixture was chilled over ice for one hour to 
allow precipitation of the product. The solvent was decanted and the product was dried 
under nitrogen flow overnight to afford S-Naproxen acid chloride as a white needle 
shaped product (280 mg, 88% yield, mp 91 - 94 "C). 
Step 2: Preparation of (S)-Citronellyl-Naproxen Ester 
To a cold solution of citronellol (35 mg, 0.22 mmol) in 5 mL dichloromethane 
(DCM) at 0 "C, (S)-Naproxen acid chloride (81 mg, 0.34 mmol), triethylamine (92 pl, 
0.66 mmol), and 4-dimethylaminopyridine (2.7 mg, 0.022 mmol) were added. The 
mixture was refluxed for 4 - 5 h or until GC revealed less than 1% citronellol. After 
cooling to room temperature (rt), hexanes (5 mL) was added and the residual salt was 
removed by filtration. The filtrate was concentrated to a crude oil, which was purified 
through a silica gel plug using hexanes. The enriched fractions were combined and 
concentrated to dryness. The diastereomeric purity was determined by I3c NMR in 
CDC13. 
C) Chiral GC 
Analytical Conditions 
All reactions were monitored by gas chromatography, Hewlett-Packard 5890 
Series I1 equipped with a flame ionization detector. The column used was a HP-5, J&W 
Scientific, 30 m x 0.32 mm. The chromatographic conditions were: split mode inlet 
(250:1), 250 "C; column temperature 60 - 175 "C at 3 "Clmin, He flow 30 mumin, 15 
psi; detector 250 "C; 10 p1 injection. The enantiomeric excess of the crude citronello1 was 
measured using a RT -BetaDEXsa column, 30 m x 0.32 mm ID x 0.25 mm, obtained 
from Restek. The Chromatographic conditions were as follow: inlet, split mode (50:1), 
150 "C; column, isothermal 80 "C, He flow 30 mumin, 15 psi, 120 min; detector 150 "C; 
10 pl injection. 
II. Asymmetric Transfer Hydrogenation 
General Procedure for Transfer Hydrogenation and Derivatization with Mosher Acid 
Chloride 
Reagents 
Geraniol (trans-3,7-dimethyl-2,6-octadien-1-01) (98% purity) dichloro-ruthenium- 
(Q-1,5-cyclooctadiene complex, [RuCODC12],, (95% purity) and the ligand (S)-(-)-2,2'- 
bis(di-p-toly1phosphino)-1,l'-binaphthyl, (S)-tolBWAP, 97% purity) were purchased 
from Aldrich. The pre-made catalyst, dichloro-[(S)-(-)-2,2'-bis(diphenylphosphino-l,1'- 
binaphthyl]ruthenium(II), [(S)-BINAP]Ru(lI)C12, was obtained from Strem in 95% assay. 
Potassium hydroxide, technical grade, was purchased from Fisher. The solvents, 1,2- 
dimethoxyethane and the N,N-dimethylforrnamide (DMF), each in anhydrous grade and 
>99.5% assay were purchased from Aldrich. The hexanes and the ethanol, HPLC grade, 
and all the other solvents (isopropanol, t-butanol, toluene, dichlorornethane, 
cyclohexanol, 2-pentanol), were purchased as ACS Grade solents from Fisher. The 
enantiomers of 2-pentanol, 98% assay, were purchased from Aldrich with optical 
activities of [ a I z 5 ~  of +13" (S) and -13" (R). The deuterated solvents, ds-isopropanol, dl2- 
cyclohexanol and dl-chloroform, were purchased from Aldrich with isotopic purities of 
99.5%, 98% and 99.96%, respectively. The R-(+)-methoxy-trifluorornethylphenylacetyl 
chloride ((R)-Mosher acid chloride, optical purity 98% and GC assay 98%), the 4- 
dirnethylarninopyridine (DMAP) and the triethylamine (TEA), reagent grades (>99% 
purity), were purchased from Aldrich. 
Analytical Conditions 
All reactions were monitored by gas chromatography, using a Hewlett-Packard 
5890 Series I1 gas chromatography equipped with a flame ionization detector. The 
column used was a HP-5, J&W Scientific, 30 rn x 0.32 mm. The chromatographic 
conditions were: split mode inlet (250:I), 250 "C; column temperature 60 - 175 OC at 3 
"Urnin, He flow 30 mumin, 15 psi; detector 250 "C; 10 p1 injection. 
The GC-MS analyses were performed on HP 5890 GC system equipped with an 
HP 5971A Mass Selective Detector and a 70 eV electron-impact ion source. 
The enantiomeric purity of the crude citronellol was measured using a RT- 
BetaDEXsa 30 m x 0.32 mm ID x 0.25 mm obtained from Restek, Bellefonte, PA. The 
chromatographic conditions were: split mode inlet (50:1), 150 "C; isothermal 80 "C, He 
flow 30 mumin, 15 psi, 120 min; detector 150 "C; 10 p1 injection. 
The diastereomeric purity of the Mosher ester of citronellol was determined on a 
Hewlett-Packard 1050 Series high performance liquid chromatography (HPLC). The 
column used was Chiralcel OJ-H, 250 mm x 4.6 mm obtained from Daicel Chemical 
Industries, Fort Lee, NJ. The mobile phase was a mixture of HPLC grade hexanesethyl 
alcohol, 90:lO to 50:50,0.6 mVmin, 20 minute gradient; room temperature; 210 and 220 
nm. The diastereomeric excess was calculated based on HPLC area percent of the R- 
Mosher-R-citronellyl ester and R-Mosher-S-citronellyl ester. All products were 
characterized using a 500 MHz Varian NMR equipped with Inova software in deuterated 
chloroform (CDC13), except for the deuterated product d3-citronellol, which was 
characterized using a 300 MHz Bruker NMR equipped with Topspin software. 
Reaction Conditions 
Asymmetric Transfer Hydrogenation 
Unless specifically indicated, all reactions were performed in a 50 mL Schlenk 
flask equipped with a teflon-coated magnetic stirrer bar. The reagents were added under a 
continuous flow of argon while the flask was placed over a liquid nitrogen bath. The 
reagents, 0.023 mmol [Ru(COD)Cl]., 0.046 mmol chiral ligand, 0.23 mmol substrate, 
0.046 mmol KOH and 20 rnL isopropanol, were added in no particular order. The flask 
was then sealed with a latex septum and subjected to three freeze-pump-thaw cycles using 
vacuum and argon. The flask was then placed in a silicone oil bath at 100 OC while 
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under a slight overpressure of argon and as soon as the solvent started to boil, the reaction 
system was closed and the mixture was stirred for 2 hours. At the end of the reaction, 
the flask was removed from the oil bath and brought to room temperature before opening 
to the atmosphere. The isopropanol was removed under reduced pressure and the 
reaction mixture was reconstituted with 2 mL of hexanes. Residual catalyst and solids 
were removed by filtration through a silica gel plug using 0% to 5% ethyl acetate in 
hexanes and the filtrate was concentrated to dryness under reduced pressure. 
Derivatization with Mosher Acid Chloride 
Same as in the Chiral Method Development Section. 
Appendix 
NMR Spectra 
and 
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Proton NMR 1,2,2-trideuterium-3,7-dimethyloct-6-en-1-01 (d3-Citronellol) 
I 
U"  M S * *  *.?a .-" .u*e --- .-0 * 
: 2: "3  '" -1 .a- ""X ": 2": 
w - .  4 a s . 2 .  rn . u s m o  
e " 
* rn 
Carbon NMR of 1,2,2-trideuterium-3,7-dimethyloct-6-en-1-01 (d3-Citronellol) 
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HMQC NMR of 1,2,2-trideuterium-3,7-dimethyloct-6-en-1-01 (d3-Citronellol) 
Deuterium NMR of 1,2,2-trideuterium-3,7-dimethyloct-6-en-1-01 (d3Citronellol) 
Chiral CG Chromatogram of S-Citronellol, R-Citronellol, Geraniol and Nerol 
Chiral GC of Citronellol (ee > 98% R) 
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